EP2406378A1 - Biokraftstoffproduktion in prokaryoten und eukaryoten - Google Patents
Biokraftstoffproduktion in prokaryoten und eukaryotenInfo
- Publication number
- EP2406378A1 EP2406378A1 EP10751219A EP10751219A EP2406378A1 EP 2406378 A1 EP2406378 A1 EP 2406378A1 EP 10751219 A EP10751219 A EP 10751219A EP 10751219 A EP10751219 A EP 10751219A EP 2406378 A1 EP2406378 A1 EP 2406378A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- vector
- synthase
- promoter
- alga
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 68
- 241000894006 Bacteria Species 0.000 title claims description 134
- 241000206602 Eukaryota Species 0.000 title description 6
- 239000002551 biofuel Substances 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 195
- 150000003505 terpenes Chemical class 0.000 claims abstract description 186
- 108010087432 terpene synthase Proteins 0.000 claims abstract description 125
- 235000007586 terpenes Nutrition 0.000 claims abstract description 96
- PZSFDLBSQBBRAM-GZRFBZBPSA-N fusicocca-2,10(14)-diene Chemical compound C1C[C@H](C)[C@@H]2CCC(C)=C2C[C@@]2(C)CCC(C(C)C)=C21 PZSFDLBSQBBRAM-GZRFBZBPSA-N 0.000 claims abstract description 90
- XMKOZZYOXTVKCX-UHFFFAOYSA-N fusicoccadiene Natural products CC1CCC2C(C(C)C)CCC2(C)CC2=C(C)CC=C21 XMKOZZYOXTVKCX-UHFFFAOYSA-N 0.000 claims abstract description 84
- 102000004190 Enzymes Human genes 0.000 claims abstract description 64
- 108090000790 Enzymes Proteins 0.000 claims abstract description 64
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 239000013598 vector Substances 0.000 claims description 301
- 150000007523 nucleic acids Chemical group 0.000 claims description 212
- 108091033319 polynucleotide Proteins 0.000 claims description 177
- 102000040430 polynucleotide Human genes 0.000 claims description 177
- 239000002157 polynucleotide Substances 0.000 claims description 177
- 102000039446 nucleic acids Human genes 0.000 claims description 174
- 108020004707 nucleic acids Proteins 0.000 claims description 174
- 235000003869 genetically modified organism Nutrition 0.000 claims description 132
- 230000000243 photosynthetic effect Effects 0.000 claims description 130
- 210000003763 chloroplast Anatomy 0.000 claims description 128
- 210000004027 cell Anatomy 0.000 claims description 127
- 125000003729 nucleotide group Chemical group 0.000 claims description 103
- 239000002773 nucleotide Substances 0.000 claims description 98
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 93
- 108020004705 Codon Proteins 0.000 claims description 92
- 230000001939 inductive effect Effects 0.000 claims description 88
- 108700010070 Codon Usage Proteins 0.000 claims description 83
- 101710107752 Geranylgeranyl diphosphate synthase Proteins 0.000 claims description 80
- 241000592342 Tracheophyta Species 0.000 claims description 72
- 230000001105 regulatory effect Effects 0.000 claims description 70
- 230000014509 gene expression Effects 0.000 claims description 66
- 241000195493 Cryptophyta Species 0.000 claims description 64
- 241000195597 Chlamydomonas reinhardtii Species 0.000 claims description 52
- 229930004069 diterpene Natural products 0.000 claims description 45
- 101710118490 Copalyl diphosphate synthase Proteins 0.000 claims description 43
- 101710174833 Tuberculosinyl adenosine transferase Proteins 0.000 claims description 42
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 39
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 39
- 150000001413 amino acids Chemical group 0.000 claims description 38
- 150000004141 diterpene derivatives Chemical class 0.000 claims description 36
- 239000003550 marker Substances 0.000 claims description 36
- 108010073469 casbene synthetase Proteins 0.000 claims description 34
- 241000199914 Dinophyceae Species 0.000 claims description 33
- 241000195623 Euglenida Species 0.000 claims description 33
- 230000009466 transformation Effects 0.000 claims description 33
- 241000195633 Dunaliella salina Species 0.000 claims description 31
- ONVABDHFQKWOSV-UHFFFAOYSA-N 16-Phyllocladene Natural products C1CC(C2)C(=C)CC32CCC2C(C)(C)CCCC2(C)C31 ONVABDHFQKWOSV-UHFFFAOYSA-N 0.000 claims description 30
- ONVABDHFQKWOSV-HPUSYDDDSA-N ent-kaur-16-ene Chemical compound C1C[C@H](C2)C(=C)C[C@@]32CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]31 ONVABDHFQKWOSV-HPUSYDDDSA-N 0.000 claims description 30
- 230000004927 fusion Effects 0.000 claims description 29
- OINNEUNVOZHBOX-QIRCYJPOSA-N 2-trans,6-trans,10-trans-geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-QIRCYJPOSA-N 0.000 claims description 26
- 241001231664 Dunaliella viridis Species 0.000 claims description 26
- -1 HxA Proteins 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- 241000192584 Synechocystis Species 0.000 claims description 26
- 241000192700 Cyanobacteria Species 0.000 claims description 25
- 101150010007 psbD gene Proteins 0.000 claims description 25
- 241000195632 Dunaliella tertiolecta Species 0.000 claims description 24
- 108010070675 Glutathione transferase Proteins 0.000 claims description 23
- 102000005720 Glutathione transferase Human genes 0.000 claims description 23
- 241000192707 Synechococcus Species 0.000 claims description 23
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 22
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 claims description 22
- 101150088806 atpA gene Proteins 0.000 claims description 22
- 101150026213 atpB gene Proteins 0.000 claims description 22
- 102000021178 chitin binding proteins Human genes 0.000 claims description 22
- 108091011157 chitin binding proteins Proteins 0.000 claims description 22
- 229910002651 NO3 Inorganic materials 0.000 claims description 21
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 21
- 230000006801 homologous recombination Effects 0.000 claims description 21
- 238000002744 homologous recombination Methods 0.000 claims description 21
- 101150099542 tuf gene Proteins 0.000 claims description 21
- 101150071165 tuf1 gene Proteins 0.000 claims description 21
- 101150010742 tuf2 gene Proteins 0.000 claims description 21
- 101150061352 tufA gene Proteins 0.000 claims description 21
- ONVABDHFQKWOSV-YQXATGRUSA-N ent-Kaur-16-ene Natural products C1C[C@@H](C2)C(=C)C[C@@]32CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]31 ONVABDHFQKWOSV-YQXATGRUSA-N 0.000 claims description 20
- UIXMIBNGPQGJJJ-UHFFFAOYSA-N ent-kaurene Natural products CC1CC23CCC4C(CCCC4(C)C)C2CCC1C3 UIXMIBNGPQGJJJ-UHFFFAOYSA-N 0.000 claims description 20
- 241000195628 Chlorophyta Species 0.000 claims description 19
- 229930027917 kanamycin Natural products 0.000 claims description 19
- 229960000318 kanamycin Drugs 0.000 claims description 19
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 19
- 229930182823 kanamycin A Natural products 0.000 claims description 19
- 241000206572 Rhodophyta Species 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 18
- 241001147674 Chlorarachniophyceae Species 0.000 claims description 17
- 241001464430 Cyanobacterium Species 0.000 claims description 17
- 241001517276 Glaucocystophyceae Species 0.000 claims description 17
- 241000206759 Haptophyceae Species 0.000 claims description 17
- 241000199919 Phaeophyceae Species 0.000 claims description 17
- 241000206761 Bacillariophyta Species 0.000 claims description 16
- 241000206751 Chrysophyceae Species 0.000 claims description 16
- 241000224472 Eustigmatophyceae Species 0.000 claims description 16
- 241001518925 Raphidophyceae Species 0.000 claims description 16
- 241000206764 Xanthophyceae Species 0.000 claims description 16
- 108010022624 abietadiene cyclase Proteins 0.000 claims description 16
- 230000001965 increasing effect Effects 0.000 claims description 16
- 108010014539 taxa-4(5),11(12)-diene synthase Proteins 0.000 claims description 16
- 241000159660 Nannochloropsis oculata Species 0.000 claims description 15
- 241000224476 Nannochloropsis salina Species 0.000 claims description 15
- PZSFDLBSQBBRAM-UHFFFAOYSA-N (+)-fusicocca-2,10(14)-diene Natural products C1CC(C)C2CCC(C)=C2CC2(C)CCC(C(C)C)=C21 PZSFDLBSQBBRAM-UHFFFAOYSA-N 0.000 claims description 14
- ZJMVJDFTNPZVMB-UHFFFAOYSA-N Casbene Chemical compound C1CC(C)=CCCC(C)=CCCC(C)=CC2C(C)(C)C12 ZJMVJDFTNPZVMB-UHFFFAOYSA-N 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 229930009323 casbene Natural products 0.000 claims description 14
- 229930017534 fusicocca-2,10(14)-diene Natural products 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- 101150075980 psbA gene Proteins 0.000 claims description 13
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims description 12
- 229960000723 ampicillin Drugs 0.000 claims description 12
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 12
- 229960005091 chloramphenicol Drugs 0.000 claims description 12
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 12
- 230000001131 transforming effect Effects 0.000 claims description 12
- 239000005561 Glufosinate Substances 0.000 claims description 11
- 102000004243 Tubulin Human genes 0.000 claims description 11
- 108090000704 Tubulin Proteins 0.000 claims description 11
- 229960002685 biotin Drugs 0.000 claims description 11
- 235000020958 biotin Nutrition 0.000 claims description 11
- 239000011616 biotin Substances 0.000 claims description 11
- BBPXZLJCPUPNGH-CMKODMSKSA-N (-)-Abietadiene Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CCC(C(C)C)=C3)C3=CC[C@H]21 BBPXZLJCPUPNGH-CMKODMSKSA-N 0.000 claims description 10
- BBPXZLJCPUPNGH-UHFFFAOYSA-N Abietadien Natural products CC1(C)CCCC2(C)C(CCC(C(C)C)=C3)C3=CCC21 BBPXZLJCPUPNGH-UHFFFAOYSA-N 0.000 claims description 10
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 10
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 10
- FRJSECSOXKQMOD-HQRMLTQVSA-N Taxa-4(5),11(12)-diene Chemical compound C1C[C@]2(C)CCC=C(C)[C@H]2C[C@@H]2CCC(C)=C1C2(C)C FRJSECSOXKQMOD-HQRMLTQVSA-N 0.000 claims description 10
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 10
- 229930014549 abietadiene Natural products 0.000 claims description 10
- 101150005124 psd gene Proteins 0.000 claims description 10
- 101150031929 ltrA gene Proteins 0.000 claims description 9
- 238000003306 harvesting Methods 0.000 claims description 8
- 125000000105 fusicocca-2,10(14)-diene group Chemical group 0.000 claims description 7
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 5
- 239000002803 fossil fuel Substances 0.000 claims description 4
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 3
- 239000003546 flue gas Substances 0.000 claims description 3
- 241000095509 Sympagurus dimorphus Species 0.000 claims 7
- 239000000446 fuel Substances 0.000 abstract description 29
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 abstract description 26
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract description 12
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 abstract description 12
- 108090000623 proteins and genes Proteins 0.000 description 187
- 239000000047 product Substances 0.000 description 136
- 241000196324 Embryophyta Species 0.000 description 100
- 102000004169 proteins and genes Human genes 0.000 description 77
- 235000018102 proteins Nutrition 0.000 description 74
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 63
- 108090000765 processed proteins & peptides Proteins 0.000 description 58
- 229920001184 polypeptide Polymers 0.000 description 55
- 102000004196 processed proteins & peptides Human genes 0.000 description 55
- 125000003275 alpha amino acid group Chemical group 0.000 description 49
- 101000892301 Phomopsis amygdali Geranylgeranyl diphosphate synthase Proteins 0.000 description 41
- 239000013604 expression vector Substances 0.000 description 34
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 30
- 229930195733 hydrocarbon Natural products 0.000 description 26
- 150000002430 hydrocarbons Chemical class 0.000 description 26
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 25
- 230000037361 pathway Effects 0.000 description 25
- 108020004414 DNA Proteins 0.000 description 23
- 150000002500 ions Chemical class 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 21
- 238000001819 mass spectrum Methods 0.000 description 21
- 239000002243 precursor Substances 0.000 description 21
- 108091092195 Intron Proteins 0.000 description 20
- 239000000758 substrate Substances 0.000 description 20
- IPFXNYPSBSIFOB-UHFFFAOYSA-N isopentyl pyrophosphate Chemical compound CC(C)CCO[P@](O)(=O)OP(O)(O)=O IPFXNYPSBSIFOB-UHFFFAOYSA-N 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 18
- 241000264606 Tetradesmus dimorphus Species 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 18
- 241000195585 Chlamydomonas Species 0.000 description 17
- 229930003658 monoterpene Natural products 0.000 description 17
- 108010064739 ent-kaurene synthetase B Proteins 0.000 description 16
- 150000002773 monoterpene derivatives Chemical class 0.000 description 16
- 230000014616 translation Effects 0.000 description 16
- 241000218631 Coniferophyta Species 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 15
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 235000002577 monoterpenes Nutrition 0.000 description 15
- 238000013519 translation Methods 0.000 description 15
- 230000002792 vascular Effects 0.000 description 15
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 14
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 14
- 210000004899 c-terminal region Anatomy 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000004215 Carbon black (E152) Substances 0.000 description 13
- 241000218922 Magnoliophyta Species 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 238000001727 in vivo Methods 0.000 description 13
- 229930004725 sesquiterpene Natural products 0.000 description 13
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 13
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 description 12
- 102000005454 Dimethylallyltranstransferase Human genes 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 12
- 108010071062 pinene cyclase I Proteins 0.000 description 12
- 230000028327 secretion Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 241000223205 Coccidioides immitis Species 0.000 description 11
- 108700024394 Exon Proteins 0.000 description 11
- 241000195663 Scenedesmus Species 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 125000000567 diterpene group Chemical group 0.000 description 11
- 239000003502 gasoline Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 108010007508 Farnesyltranstransferase Proteins 0.000 description 10
- 241000223195 Fusarium graminearum Species 0.000 description 10
- 102100039291 Geranylgeranyl pyrophosphate synthase Human genes 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 210000002706 plastid Anatomy 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 101710135150 (+)-T-muurolol synthase ((2E,6E)-farnesyl diphosphate cyclizing) Proteins 0.000 description 9
- 101710119400 Geranylfarnesyl diphosphate synthase Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 101710093888 Pentalenene synthase Proteins 0.000 description 9
- 101710115850 Sesquiterpene synthase Proteins 0.000 description 9
- 238000009825 accumulation Methods 0.000 description 9
- 238000005336 cracking Methods 0.000 description 9
- 238000012239 gene modification Methods 0.000 description 9
- 230000005017 genetic modification Effects 0.000 description 9
- 235000013617 genetically modified food Nutrition 0.000 description 9
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 9
- 238000002703 mutagenesis Methods 0.000 description 9
- 231100000350 mutagenesis Toxicity 0.000 description 9
- 229930014626 natural product Natural products 0.000 description 9
- 210000004940 nucleus Anatomy 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000007363 ring formation reaction Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 7
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 7
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 7
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical class CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 239000011324 bead Substances 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000019525 primary metabolic process Effects 0.000 description 7
- 150000003431 steroids Chemical class 0.000 description 7
- 230000008685 targeting Effects 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- 101710095468 Cyclase Proteins 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 240000000528 Ricinus communis Species 0.000 description 6
- 235000004443 Ricinus communis Nutrition 0.000 description 6
- 235000021466 carotenoid Nutrition 0.000 description 6
- 150000001747 carotenoids Chemical class 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000003348 petrochemical agent Substances 0.000 description 6
- 238000007670 refining Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 230000024053 secondary metabolic process Effects 0.000 description 6
- 150000003648 triterpenes Chemical class 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 108700008625 Reporter Genes Proteins 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000003350 kerosene Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 230000008520 organization Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- IHPKGUQCSIINRJ-CSKARUKUSA-N (E)-beta-ocimene Chemical compound CC(C)=CC\C=C(/C)C=C IHPKGUQCSIINRJ-CSKARUKUSA-N 0.000 description 4
- 101710195549 (S)-beta-macrocarpene synthase Proteins 0.000 description 4
- 101100081573 Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) oblA gene Proteins 0.000 description 4
- 241001474374 Blennius Species 0.000 description 4
- 241001306278 Diaporthe amygdali Species 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 102000019337 Prenyltransferases Human genes 0.000 description 4
- 108050006837 Prenyltransferases Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 239000007833 carbon precursor Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 230000029553 photosynthesis Effects 0.000 description 4
- 238000010672 photosynthesis Methods 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 150000003535 tetraterpenes Chemical class 0.000 description 4
- YHBUQBJHSRGZNF-UHFFFAOYSA-N trans-α-Bisabolene Chemical compound CC(C)=CCC=C(C)C1CCC(C)=CC1 YHBUQBJHSRGZNF-UHFFFAOYSA-N 0.000 description 4
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 description 3
- 241000228193 Aspergillus clavatus Species 0.000 description 3
- 241000221955 Chaetomium Species 0.000 description 3
- 108091092584 GDNA Proteins 0.000 description 3
- 229930191978 Gibberellin Natural products 0.000 description 3
- 108090000769 Isomerases Proteins 0.000 description 3
- 102000004195 Isomerases Human genes 0.000 description 3
- 108010025815 Kanamycin Kinase Proteins 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010085220 Multiprotein Complexes Proteins 0.000 description 3
- 102000007474 Multiprotein Complexes Human genes 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 3
- 108010022394 Threonine synthase Proteins 0.000 description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 3
- 101150067314 aadA gene Proteins 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 125000000746 allylic group Chemical group 0.000 description 3
- 229940009098 aspartate Drugs 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 102000004419 dihydrofolate reductase Human genes 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- XWRJRXQNOHXIOX-UHFFFAOYSA-N geranylgeraniol Natural products CC(C)=CCCC(C)=CCOCC=C(C)CCC=C(C)C XWRJRXQNOHXIOX-UHFFFAOYSA-N 0.000 description 3
- 125000002686 geranylgeranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- OJISWRZIEWCUBN-UHFFFAOYSA-N geranylnerol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO OJISWRZIEWCUBN-UHFFFAOYSA-N 0.000 description 3
- 239000003448 gibberellin Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- 125000002298 terpene group Chemical group 0.000 description 3
- 235000009657 tetraterpenes Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 239000012130 whole-cell lysate Substances 0.000 description 3
- 229910052726 zirconium Inorganic materials 0.000 description 3
- YONHOSLUBQJXPR-UMVBOHGHSA-N (+)-5-epi-aristolochene Chemical compound C1[C@@H](C(C)=C)C[C@]2(C)[C@H](C)CCCC2=C1 YONHOSLUBQJXPR-UMVBOHGHSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Chemical compound C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 2
- XMGQYMWWDOXHJM-SNVBAGLBSA-N (-)-α-limonene Chemical compound CC(=C)[C@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-SNVBAGLBSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- VEGYMPQCXPVQJY-UHFFFAOYSA-N (10ξ)-eudesma-4,6-diene Chemical compound C1CCC2(C)CCC(C(C)C)=CC2=C1C VEGYMPQCXPVQJY-UHFFFAOYSA-N 0.000 description 2
- 229930000060 (E)-alpha-bisabolene Natural products 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- NDUIFQPPDDOKRN-UHFFFAOYSA-N 4,6,6-trimethylbicyclo[3.1.1]hept-4-ene Chemical compound C1CC(C)=C2C(C)(C)C1C2 NDUIFQPPDDOKRN-UHFFFAOYSA-N 0.000 description 2
- JCAIWDXKLCEQEO-PGHZQYBFSA-N 5beta,9alpha,10alpha-labda-8(20),13-dien-15-yl diphosphate Chemical compound CC1(C)CCC[C@@]2(C)[C@H](CCC(/C)=C/COP(O)(=O)OP(O)(O)=O)C(=C)CC[C@@H]21 JCAIWDXKLCEQEO-PGHZQYBFSA-N 0.000 description 2
- 244000178606 Abies grandis Species 0.000 description 2
- 235000017894 Abies grandis Nutrition 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241001147477 Cyclotella cryptica Species 0.000 description 2
- 108010054248 Delta-selinene synthase Proteins 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 101710147220 Ent-copalyl diphosphate synthase, chloroplastic Proteins 0.000 description 2
- 101710114727 Ent-kaur-16-ene synthase, chloroplastic Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 241000219146 Gossypium Species 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 101150103876 PaFS gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000192581 Synechocystis sp. Species 0.000 description 2
- 241000202349 Taxus brevifolia Species 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- HMTAHNDPLDKYJT-CBBWQLFWSA-N amorpha-4,11-diene Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(C)=C)[C@H]21 HMTAHNDPLDKYJT-CBBWQLFWSA-N 0.000 description 2
- HMTAHNDPLDKYJT-UHFFFAOYSA-N amorphadiene Natural products C1=C(C)CCC2C(C)CCC(C(C)=C)C21 HMTAHNDPLDKYJT-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- YONHOSLUBQJXPR-UHFFFAOYSA-N aristolochene Natural products C1C(C(C)=C)CC2(C)C(C)CCCC2=C1 YONHOSLUBQJXPR-UHFFFAOYSA-N 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004517 catalytic hydrocracking Methods 0.000 description 2
- 238000001833 catalytic reforming Methods 0.000 description 2
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 2
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 2
- 229940026455 cedrol Drugs 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000004939 coking Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 150000001924 cycloalkanes Chemical class 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 210000000172 cytosol Anatomy 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010050355 farnesylpyrophosphate cyclase Proteins 0.000 description 2
- 238000004231 fluid catalytic cracking Methods 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000002816 fuel additive Substances 0.000 description 2
- 239000000295 fuel oil Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 235000014304 histidine Nutrition 0.000 description 2
- 101150024506 hpf gene Proteins 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000010687 lubricating oil Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical group CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 101150008418 psbY gene Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- BQOFWKZOCNGFEC-BDAKNGLRSA-N (+)-Delta3-carene Chemical compound C1C(C)=CC[C@H]2C(C)(C)[C@@H]12 BQOFWKZOCNGFEC-BDAKNGLRSA-N 0.000 description 1
- 108030001864 (+)-bornyl diphosphate synthases Proteins 0.000 description 1
- 229930006713 (+)-car-3-ene Natural products 0.000 description 1
- 108030004879 (+)-delta-cadinene synthases Proteins 0.000 description 1
- 108030004087 (+)-sabinene synthases Proteins 0.000 description 1
- 229960003595 (-)- limonene Drugs 0.000 description 1
- 108010035061 (-)-alpha-pinene synthase Proteins 0.000 description 1
- 108030004260 (-)-beta-pinene synthases Proteins 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- MAKBWIUHFAVVJP-HAXARLPTSA-N (2R,3S)-pentane-1,2,3,4-tetrol phosphoric acid Chemical compound OP(O)(O)=O.CC(O)[C@H](O)[C@H](O)CO MAKBWIUHFAVVJP-HAXARLPTSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 1
- 108010070036 (E)-alpha-bisabolene synthase Proteins 0.000 description 1
- 101710100916 (E)-beta-farnesene synthase Proteins 0.000 description 1
- 108030004942 (E)-gamma-bisabolene synthases Proteins 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- 101710129983 (E,E)-alpha-farnesene synthase Proteins 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- 108030004093 1,8-cineole synthases Proteins 0.000 description 1
- 108700020469 14-3-3 Proteins 0.000 description 1
- 102000004899 14-3-3 Proteins Human genes 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
- HHXYJYBYNZMZKX-PYQRSULMSA-N 22(29)-Hopene Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1C(=C)C HHXYJYBYNZMZKX-PYQRSULMSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- IVBZYUKCNLJUDA-UHFFFAOYSA-N 3,3a,6-trimethyl-1-(propan-2-yl)-2,3,3a,4-tetrahydro-1h-indene Chemical compound C1C=C(C)C=C2C(C(C)C)CC(C)C21C IVBZYUKCNLJUDA-UHFFFAOYSA-N 0.000 description 1
- HHXYJYBYNZMZKX-UHFFFAOYSA-N 3,4:15,16-diepoxy-7-oxo-13(16),14-clerodadien-20,12-olide-(3alpha,4alpha)-form Natural products C12CCC3C4(C)CCCC(C)(C)C4CCC3(C)C1(C)CCC1C2(C)CCC1C(=C)C HHXYJYBYNZMZKX-UHFFFAOYSA-N 0.000 description 1
- 108010014293 5-epi-aristolochene synthase Proteins 0.000 description 1
- JCAIWDXKLCEQEO-ATPOGHATSA-N 5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CCC(/C)=C/COP(O)(=O)OP(O)(O)=O)C(=C)CC[C@H]21 JCAIWDXKLCEQEO-ATPOGHATSA-N 0.000 description 1
- 108010000951 8-epicedrol synthase Proteins 0.000 description 1
- 101000762834 Abies grandis Copalyl diphosphate synthase Proteins 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 101100068321 Aequorea victoria GFP gene Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 101100301006 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) cbbL2 gene Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101710151101 Alpha-zingiberene synthase Proteins 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 101000906787 Arabidopsis thaliana 1,8-cineole synthase 1, chloroplastic Proteins 0.000 description 1
- 101000906782 Arabidopsis thaliana 1,8-cineole synthase 2, chloroplastic Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 108010031937 Aristolochene synthase Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 101710137820 Beta-caryophyllene synthase Proteins 0.000 description 1
- 101710129460 Beta-phellandrene synthase Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 108030000358 Botryococcene synthases Proteins 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000006463 Brassica alba Nutrition 0.000 description 1
- 244000060924 Brassica campestris Species 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 235000005156 Brassica carinata Nutrition 0.000 description 1
- 244000257790 Brassica carinata Species 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 235000014700 Brassica juncea var napiformis Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011291 Brassica nigra Nutrition 0.000 description 1
- 244000180419 Brassica nigra Species 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- VZHHNDCSESIXJW-UHFFFAOYSA-N C(=CC(C)=C)OP(=O)(O)OP(=O)(O)O Chemical compound C(=CC(C)=C)OP(=O)(O)OP(=O)(O)O VZHHNDCSESIXJW-UHFFFAOYSA-N 0.000 description 1
- 101100178679 Caenorhabditis elegans hsp-1 gene Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 101710168515 Cell surface glycoprotein Proteins 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 108020004998 Chloroplast DNA Proteins 0.000 description 1
- 108700031407 Chloroplast Genes Proteins 0.000 description 1
- 108030003505 Cis-muuroladiene synthases Proteins 0.000 description 1
- 241000219930 Clarkia Species 0.000 description 1
- 241000226657 Clarkia concinna Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- JCAIWDXKLCEQEO-LXOWHHAPSA-N Copalyl diphosphate Natural products [P@@](=O)(OP(=O)(O)O)(OC/C=C(\CC[C@H]1C(=C)CC[C@H]2C(C)(C)CCC[C@@]12C)/C)O JCAIWDXKLCEQEO-LXOWHHAPSA-N 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- BQOFWKZOCNGFEC-UHFFFAOYSA-N Delta3-Carene Natural products C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 101150051221 Dl gene Proteins 0.000 description 1
- 101100018009 Drosophila melanogaster Hsp70Aa gene Proteins 0.000 description 1
- 101100507660 Drosophila melanogaster Hsp70Ab gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- 108030004983 Epi-cedrol synthases Proteins 0.000 description 1
- XVULBTBTFGYVRC-UHFFFAOYSA-N Episclareol Natural products CC1(C)CCCC2(C)C(CCC(O)(C)C=C)C(C)(O)CCC21 XVULBTBTFGYVRC-UHFFFAOYSA-N 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000195620 Euglena Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 1
- 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 description 1
- 101710125754 Farnesyl pyrophosphate synthase Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- KXTYBXCEQOANSX-UHFFFAOYSA-N Fusicoccin A Natural products C12=C(C(C)COC(C)=O)CC(O)C2(C)C=C2C(COC)CCC2C(C)C(O)C1OC1OC(COC(C)(C)C=C)C(O)C(OC(C)=O)C1O KXTYBXCEQOANSX-UHFFFAOYSA-N 0.000 description 1
- 108010061047 Gamma-humulene synthase Proteins 0.000 description 1
- 108030004269 Gamma-terpinene synthases Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 108010026318 Geranyltranstransferase Proteins 0.000 description 1
- 108010048467 Germacrene C synthase Proteins 0.000 description 1
- 108030004951 Germacrene-A synthases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 235000014751 Gossypium arboreum Nutrition 0.000 description 1
- 240000001814 Gossypium arboreum Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000168525 Haematococcus Species 0.000 description 1
- 101001009859 Herpetosiphon aurantiacus (strain ATCC 23779 / DSM 785 / 114-95) (+)-kolavenyl diphosphate synthase Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000664737 Homo sapiens Somatotropin Proteins 0.000 description 1
- 229930186351 Hopene Natural products 0.000 description 1
- 241001495123 Hyoscyamus muticus Species 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 101710183158 Isopimaradiene synthase Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108030004940 Longifolene synthases Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108700005089 MHC Class I Genes Proteins 0.000 description 1
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000182802 Mentha sylvestris Species 0.000 description 1
- 235000002901 Mentha sylvestris Nutrition 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- 108030004881 Myrcene synthases Proteins 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- 241000224474 Nannochloropsis Species 0.000 description 1
- 101000737877 Nicotiana suaveolens 1,8-cineol synthase, chloroplastic Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101000894711 Origanum vulgare Bicyclo-germacrene synthase Proteins 0.000 description 1
- 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 241000192497 Oscillatoria Species 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736122 Parastagonospora nodorum Species 0.000 description 1
- 108010085387 Patchoulol synthase Proteins 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
- 108010035235 Phleomycins Proteins 0.000 description 1
- 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 241000192511 Pseudanabaena Species 0.000 description 1
- 241000221037 Pyrularia pubera Species 0.000 description 1
- 101150111829 RBCS2 gene Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108010052090 Renilla Luciferases Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 101710099182 S-layer protein Proteins 0.000 description 1
- 108010018903 S-linalool synthase Proteins 0.000 description 1
- 101000737868 Salvia fruticosa Cineole synthase 1, chloroplastic Proteins 0.000 description 1
- 101000588121 Santalum album (+)-alpha-terpineol synthase Proteins 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108030000407 Syn-copalyl-diphosphate synthases Proteins 0.000 description 1
- 108030004977 Syn-pimara-7,15-diene synthases Proteins 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 101000674612 Taxus brevifolia Taxadiene synthase Proteins 0.000 description 1
- 108030004268 Terpinolene synthases Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 101100487933 Thermostichus vulcanus ycf12 gene Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108030003566 Valencene synthases Proteins 0.000 description 1
- 108010053355 Vetispiradiene synthase Proteins 0.000 description 1
- 101000720152 Zea mays Acyclic sesquiterpene synthase Proteins 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- 150000004808 allyl alcohols Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 102000006646 aminoglycoside phosphotransferase Human genes 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- NERNKRPBSOBEHC-UHFFFAOYSA-N anti-copalol Natural products CC1(C)CCCC2(C)C(CCC(C)=CCO)C(=C)CCC21 NERNKRPBSOBEHC-UHFFFAOYSA-N 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 229910001570 bauxite Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NDVASEGYNIMXJL-UHFFFAOYSA-N beta-sabinene Natural products C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004523 catalytic cracking Methods 0.000 description 1
- 101150004101 cbbL gene Proteins 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- AORLUAKWVIEOLL-UHFFFAOYSA-N chrysanthemyl diphosphate Chemical compound CC(C)=CC1C(COP(O)(=O)OP(O)(O)=O)C1(C)C AORLUAKWVIEOLL-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000007350 electrophilic reaction Methods 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- CECREIRZLPLYDM-UHFFFAOYSA-N ent-epimanool Natural products CC1(C)CCCC2(C)C(CCC(O)(C)C=C)C(=C)CCC21 CECREIRZLPLYDM-UHFFFAOYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- KXTYBXCEQOANSX-WYKQKOHHSA-N fusicoccin Chemical compound O([C@H]1[C@H](O)[C@H](C)[C@@H]\2CC[C@@H](C/2=C/[C@@]2(C)[C@@H](O)CC(=C21)[C@H](C)COC(C)=O)COC)[C@H]1O[C@H](COC(C)(C)C=C)[C@@H](O)[C@H](OC(C)=O)[C@H]1O KXTYBXCEQOANSX-WYKQKOHHSA-N 0.000 description 1
- FEQSXXYJWMCXJX-UHFFFAOYSA-N fusicoccin J Natural products C12=C(C(C)C)CC(O)C2(C)C=C2C(COC)CCC2C(C)C(O)C1OC1OC(COC(C)(C)C=C)C(O)C(O)C1O FEQSXXYJWMCXJX-UHFFFAOYSA-N 0.000 description 1
- FEQSXXYJWMCXJX-FMYGVZKHSA-N fusicoccin j Chemical compound O([C@H]1[C@H](O)[C@H](C)[C@@H]\2CC[C@@H](C/2=C/[C@@]2(C)[C@@H](O)CC(=C21)C(C)C)COC)[C@H]1O[C@H](COC(C)(C)C=C)[C@@H](O)[C@H](O)[C@H]1O FEQSXXYJWMCXJX-FMYGVZKHSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002411 histidines Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 108010091662 levopimaradiene synthase Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- CECREIRZLPLYDM-QGZVKYPTSA-N manool Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CC[C@](O)(C)C=C)C(=C)CC[C@H]21 CECREIRZLPLYDM-QGZVKYPTSA-N 0.000 description 1
- JKMAMXHNJFUAFT-UHFFFAOYSA-N manool Natural products CC1(C)CCCC2(C)C(CCC(O)C=C)C(=C)CCC12 JKMAMXHNJFUAFT-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000001220 mentha spicata Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- DBJYYRBULROVQT-UHFFFAOYSA-N platinum rhenium Chemical compound [Re].[Pt] DBJYYRBULROVQT-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 101150096384 psaD gene Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 101150074945 rbcL gene Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 101150065751 tps gene Proteins 0.000 description 1
- 101150007587 tpx gene Proteins 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000005820 transferase reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8249—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving ethylene biosynthesis, senescence or fruit development, e.g. modified tomato ripening, cut flower shelf-life
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
Definitions
- Liquid fuels are primarily composed of mixtures of paraffinic and aromatic hydrocarbons.
- Terpenes are a class of biologically produced molecules synthesized from five carbon precursor molecules in a wide range of organisms. Terpenes are pure hydrocarbons, while terpenoids may contain one or more oxygen atoms. Because terpenes are hydrocarbons with a low oxygen content and contain no nitrogen or other heteroatoms, terpenes can be used as fuel components with minimal processing.
- terpenes are fusicoccadiene, casbene, ent-kaurene, taxadiene, and abietadiene.
- Described herein are methods and compositions for the production of terpenes and terpenoids for use as fuel molecules or components.
- polynucleotide capable of transforming a photosynthetic bacterium, a yeast, an alga, or a vascular plant, wherein the polynucleotide comprises a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO:4, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 54, or SEQ ID NO: 56.
- the genome is a chloroplast genome of the alga or the vascular plant. 5.
- the alga is a microalga.
- the isolated polynucleotide of claim 1, wherein the alga is C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, D. tertiolecta, N. oculata, or N. salina. 10.
- alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heterozziphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a raphidophyta, a phaeophyta, or a phytoplankton.
- the tag is a His-6 tag, a FLAG epitope, a c-myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- An isolated polynucleotide capable of transforming a photosynthetic bacterium, a yeast, an alga, or a vascular plant comprising a nucleic acid encoding a terpene synthase comprising, (a) an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55; or (b) a homolog of the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- the terpene synthase comprises the amino acid sequence of SEQ ID NO: 2.
- alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heteronochphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a raphidophyta, a phaeophyta, or a phytoplankton. 25.
- a cyanophyta cyanophyta
- a vector comprising a polynucleotide comprising a nucleic acid encoding a terpene synthase, wherein the terpene synthase cyclyzes a terpene, and wherein the terpene synthase is capable of being expressed in a photosynthetic bacterium, a yeast, an alga, or a vascular plant.
- the nucleic acid is codon biased for expression in the photosynthetic bacterium, yeast, alga, or vascular plant.
- the codon bias is hot codon bias.
- the codon bias is regular codon bias.
- 32. The vector of claim 31, wherein the diterpene synthase is a fusicoccadiene synthase or a homolog of a fusicoccadiene synthase. 33.
- nucleic acid comprises a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO:4, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 54, or SEQ ID NO: 56. 34.
- nucleic acid comprises a nucleotide sequence of SEQ ID NO: 4, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 28, SEQ ID NO: 34, or SEQ ID NO: 39. 35.
- nucleic acid encoding a terpene synthase comprises, (a) an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55; or (b) a homolog of the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55. 36.
- the vector of claim 35 wherein the homolog has at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- the terpene synthase comprises an amino acid sequence of SEQ ID NO: 2.
- the nucleic acid comprises a nucleotide sequence of SEQ ID.
- the vector of claim 38, wherein the nucleic acid comprises the nucleotide sequence of SEQ ID. NO: 7.
- GGPP geranylgeranyl-diphosphate
- the polynucleotide further comprises a promoter for expression in the photosynthetic bacterium, yeast, alga, or vascular plant.
- the promoter is a constitutive promoter.
- the promoter is an inducible promoter.
- the inducible promoter is a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter.
- the promoter is T7, psbD, psdA, tufA, ltrA, atpA, or tubulin. 53.
- the vector of claim 48, wherein the promoter is a chloroplast promoter.
- 54. The vector of claim 48, wherein the promoter is psbA, psbD, atpA, or tufA.
- 55. The vector of any one of claims 48 to 54, wherein the promoter is operably linked to the polynucleotide.
- 56. The vector of claim 26, wherein said vector further comprises a 5' regulatory region.
- said 5' regulatory region further comprises a promoter.
- 58. The vector of claim 57, wherein said promoter is a constitutive promoter.
- 59. The vector of claim 57, wherein said promoter is an inducible promoter. 60.
- the vector of claim 59 wherein said inducible promoter is a light inducible promoter, nitrate inducible promoter, or a heat responsive promoter.
- said inducible promoter is a light inducible promoter, nitrate inducible promoter, or a heat responsive promoter.
- the vector of any one of claims 56 to 60 further comprising a 3' regulatory region.
- the polynucleotide further comprises a nucleic acid which facilitates homologous recombination into a genome of the photosynthetic bacterium, yeast, alga, or vascular plant. 64.
- the vector of claim 63 wherein the genome is a chloroplast genome of the alga or the vascular plant. 65. The vector of claim 63, wherein the genome is a nuclear genome of the yeast, the alga, or the vascular plant. 66. The vector of claim 26, wherein the photosynthetic bacterium is a member of genera Synechocystis, genera Synechococcus, or genera Athrospira. 67. The vector of claim 26, wherein the photosynthetic bacterium is a cyanobacterium. 68. The vector of claim 26, wherein the alga is a microalga. 69. The vector of claim 26, wherein the alga is C. reinhardtii, D. salina, H.
- alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heteronochphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a
- the polynucleotide further comprises a nucleic acid encoding a tag for purification or detection of the terpene synthase.
- the tag is a His-6 tag, a FLAG epitope, a c-myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- the polynucleotide further comprises a nucleic acid encoding a selectable marker.
- the selectable marker is kanamycin, chloramphenicol, ampicillin, or glufosinate.
- the photosynthetic bacterium, yeast, alga, or vascular plant does not normally produce the terpene.
- a vector comprising, a polynucleotide comprising a nucleic acid sequence of SEQ ID NO: 46, SEQ ID NO: 51, or SEQ ID NO: 56.
- the vector of claim 77 wherein the nucleic acid sequence is operably linked to a promoter in a host organism.
- the promoter is a constitutive promoter.
- the promoter is an inducible promoter.
- the inducible promoter is a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter.
- the vector of claim 78, wherein the promoter is T7, psbD, psdA, tufA, ltrA, atpA, or tubulin.
- the promoter is a chloroplast promoter.
- the promoter is psbA, psbD, atpA, or tufA.
- the organism is a photosynthetic bacterium, a yeast, an alga, or a vascular plant. 86.
- the vector of claim 85 wherein the photosynthetic bacterium is a member of genera Synechocystis, genera Synechococcus, or genera Athrospira. 87.
- the vector of claim 85 wherein the alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heterozziphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a raphidophyta, a phaeophyta, or a phytoplankton.
- a vector comprising a polynucleotide comprising a nucleic acid encoding an enzyme capable of modulating a terpenoid biosynthetic pathway in an organism wherein the organism is a photosynthetic bacterium, a yeast, an alga, or a vascular plant.
- the nucleic acid is codon biased for expression in the photosynthetic bacterium, yeast, alga, or vascular plant.
- the codon bias is hot codon bias.
- the codon bias is regular codon bias.
- the vector of claim 91, wherein the enzyme is a terpene synthase.
- the terpene synthase is a diterpene synthase.
- the diterpene synthase is a fusicoccadiene synthase, a kaurene synthase, a casbene synthase, a taxadiene synthase, an abietadiene synthase, or a homolog of any one of the above. 98.
- the vector of claim 97 wherein the diterpene synthase is a fusicoccadiene synthase or a homolog of a fusicoccadiene synthase.
- the nucleic acid comprises a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO:4, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 54, or SEQ ID NO: 56.
- nucleic acid comprises a nucleotide sequence of SEQ ID NO: 4, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 28, SEQ ID NO: 34, or SEQ ID NO: 39. 101.
- the vector of claim 95 wherein the terpene synthase comprises, (a) an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55;or (b) a homolog of the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55. 102.
- the vector of claim 101 wherein the homolog has at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- the vector of 103 wherein the fusion terpene synthase comprises a portion of a casbene synthase and a portion of a geranylgeranyl-diphosphate (GGPP) synthase.
- the vector of 104 wherein the fusion terpene synthase comprises the amino acid sequence of SEQ ID NO: 22.
- 106 The vector of any one of claims 91-105, wherein the polynucleotide further comprises a promoter for expression in the photosynthetic bacterium, yeast, alga, or vascular plant. 107.
- the vector of claim 106 wherein the promoter is a constitutive promoter.
- the vector of claim 106 wherein the promoter is an inducible promoter.
- the inducible promoter is a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter.
- the promoter is T7, psbD, psdA, tufA, ltrA, atpA, or tubulin.
- the promoter is a chloroplast promoter. 112.
- the vector of claim 106, wherein the promoter is psbA, psbD, atpA, or tufA. 113.
- said inducible promoter is a light inducible promoter, nitrate inducible promoter, or a heat responsive promoter.
- 120. The vector of any one of claims 115 to 118, wherein the promoter is operably linked to the polynucleotide.
- 121. The vector of any one of claims 91 to 120, wherein the polynucleotide further comprises a nucleic acid which facilitates homologous recombination into a genome of the photosynthetic bacterium, yeast, alga, or vascular plant.
- the vector of claim 121, wherein the genome is a chloroplast genome of the alga or the vascular plant.
- 123. The vector of claim 121, wherein the genome is a nuclear genome of the yeast, the alga, or the vascular plant.
- the vector of claim 91, wherein the photosynthetic bacterium is a member of genera Synechocystis, genera Synechococcus, or genera Athrospira. 125.
- the vector of claim 91, wherein the photosynthetic bacterium is a cyanobacterium.
- the vector of claim 91, wherein the alga is a microalga. 127.
- the vector of claim 91, wherein the alga is C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, D. tertiolecta, N. oculata, or N. salina. 128.
- the vector of claim 91 wherein the alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heteroachiphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a raphidophyta, a phaeophyta, or a phytoplankton.
- the polynucleotide further comprises a nucleic acid encoding a tag for purification or detection of the terpene synthase.
- the tag is a His-6 tag, a FLAG epitope, a c-myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- the polynucleotide further comprises a nucleic acid encoding a selectable marker.
- the selectable marker is kanamycin, chloramphenicol, ampicillin, or glufosinate. [0012] 134.
- a genetically modified organism comprising a polynucleotide comprising a nucleic acid encoding a terpene synthase, wherein the terpene synthase cyclyzes a terpene, and wherein the terpene synthase is capable of being expressed in the organism, and wherein the organism is a photosynthetic bacterium, a yeast, an alga, or a vascular plant. 135.
- the codon bias is hot codon bias.
- the terpene synthase is a diterpene synthase.
- the diterpene synthase is a fusicoccadiene synthase, a kaurene synthase, a casbene synthase, a taxadiene synthase, an abietadiene synthase, or a homolog of any one of the above.
- the genetically modified organism of claim 139 wherein the diterpene synthase is a fusicoccadiene synthase or a homolog of a fusicoccadiene synthase.
- the nucleic acid comprises a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO:4, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 54, or SEQ ID NO: 56.
- nucleic acid comprises a nucleotide sequence of SEQ ID NO: 4, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 28, SEQ ID NO: 34, or SEQ ID NO: 39. 143.
- nucleic acid encoding a terpene synthase comprises, (a) an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55; or (b) a homolog of the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- SEQ ID NO: 2 amino acid sequence of SEQ ID NO: 2
- SEQ ID NO: 10 amino acid sequence of SEQ ID NO: 16
- SEQ ID NO: 27 amino acid sequence of SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO
- the genetically modified organism of claim 143 wherein the homolog has at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- the genetically modified organism of claim 134 wherein the nucleic acid comprises a nucleotide sequence of SEQ ID. NO: 4 or SEQ ID. NO: 7. 147.
- the genetically modified organism of claim 134, wherein the nucleic acid comprises the nucleotide sequence of SEQ ID. NO: 7.
- the terpene is a diterpene.
- the genetically modified organism of claim 134 wherein the terpene is a fusicoccadiene, a casbene, an ent-kaurene, a taxadiene, or an abietadiene.
- the fusicoccadiene is fusicocca-2,10(14)-diene.
- the genetically modified organism of claim 153 wherein the fusion terpene synthase comprises a portion of a casbene synthase and a portion of a geranylgeranyl- diphosphate (GGPP) synthase.
- GGPP geranylgeranyl- diphosphate
- 155 The genetically modified organism of claim 154, wherein the fusion terpene synthase comprises the amino acid sequence of SEQ ID NO: 22.
- the polynucleotide further comprises a promoter for expression in the photosynthetic bacterium, yeast, alga, or vascular plant.
- the promoter is a constitutive promoter. 158.
- the genetically modified organism of claim 156 wherein the promoter is an inducible promoter.
- the inducible promoter is a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter.
- the promoter is T7, psbD, psdA, tufA, ltrA, atpA, or tubulin. 161.
- the genetically modified organism of claim 156, wherein the promoter is a chloroplast promoter. 162.
- the genetically modified organism of claim 134, wherein the polynucleotide further comprises a 5' regulatory region.
- said 5' regulatory region further comprises a promoter.
- said promoter is an inducible promoter. 168.
- the genetically modified organism of claim 167 wherein said inducible promoter is a light inducible promoter, nitrate inducible promoter, or a heat responsive promoter.
- said inducible promoter is a light inducible promoter, nitrate inducible promoter, or a heat responsive promoter.
- the genetically modified organism of any one of claim 134-170, wherein the polynucleotide further comprises a nucleic acid which facilitates homologous recombination into a genome of the photosynthetic bacterium, yeast, alga, or vascular plant. 172.
- the genetically modified organism of claim 134 wherein the alga is C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, D. tertiolecta, N. oculata, or N. salina. 178.
- the genetically modified organism of claim 134 wherein the alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heteroachiphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eustigmatophyta, a raphidophyta, a phaeophyta, or a phytoplankton.
- the polynucleotide further comprises a nucleic acid encoding a tag for purification or detection of the terpene synthase.
- the tag is a His-6 tag, a FLAG epitope, a c- myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- GST glutathione S-transferase
- CBP chitin binding protein
- MBP maltose binding protein
- the genetically modified organism of claim 134 wherein the polynucleotide further comprises a nucleic acid encoding an amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 12, SEQ ID NO: 19, SEQ ID NO: 23, or SEQ ID NO: 29. 182.
- the selectable marker is kanamycin, chloramphenicol, ampicillin, or glufosinate.
- the photosynthetic bacterium, yeast, alga, or vascular plant does not normally produce the terpene.
- the genetically modified organism of claim 134 wherein at least 0.24%, at least 0.5%, at least 0.75%, or at least 1.0% dry weight of the organism is the terpene.
- the genetically modified organism of claim 134 wherein at least 0.05%, at least 0.1%, at least 0.25%, at least 0.5%, at least 0.75%, at least 1.0%, at least 1.25%, at least 1.5%, at least 1.75%, at least 2.0 %, at least 3.0%, at least 4.0%, or at least 5.0% dry weight of the organism is the terpene.
- the genetically modified organism of claim 134, wherein the genetically modified organism is capable of growing in a high saline environment. 188.
- the genetically modified organism of claim 187 wherein the organism is alga. 189.
- the genetically modified organism of claim 187, wherein the high saline environment comprises sodium chloride.
- the sodium chloride is about 0.5 to about 4.0 molar sodium chloride.
- a composition comprising at least 3% terpene and at least a trace amount of a cellular portion of a genetically modified organism.
- a method of producing a product comprising: a) transforming an organism with a polynucleotide comprising a nucleic acid encoding a terpene synthase capable of being expressed in the organism, wherein the transformation results in the production or increased production of a terpene, and wherein the organism is a photosynthetic bacterium, a yeast, an alga, or a vascular plant; b) collecting the terpene from the transformed organism; and c) using the terpene to produce a product.
- the nucleic acid is codon biased for expression in the photosynthetic bacterium, yeast, alga, or vascular plant.
- the diterpene synthase is a fusicoccadiene synthase or a homolog of a fusicoccadiene synthase.
- the nucleic acid comprises a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO:4, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 54, or SEQ ID NO: 56.
- nucleic acid comprises a nucleotide sequence of SEQ ID NO: 4, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 28, SEQ ID NO: 34, or SEQ ID NO: 39. 202.
- nucleic acid encoding a terpene synthase comprises, (a) an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55; or (b) a homolog of the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- SEQ ID NO: 2 amino acid sequence of SEQ ID NO: 2
- SEQ ID NO: 10 amino acid sequence of SEQ ID NO: 16
- SEQ ID NO: 27 amino acid sequence of SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO
- the method of claim 202 wherein the homolog has at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 10, SEQ ID NO: 16, SEQ ID NO: 22, SEQ ID NO: 27, SEQ ID NO: 33, SEQ ID NO: 38, SEQ ID NO: 45, SEQ ID NO: 50, or SEQ ID NO: 55.
- the terpene synthase comprises an amino acid sequence of SEQ ID NO: 2.
- nucleic acid comprises a nucleotide sequence of SEQ ID. NO: 4 or SEQ ID. NO: 7.
- the nucleic acid comprises the nucleotide sequence of SEQ ID. NO: 7.
- the terpene is a diterpene.
- the diterpene is a cyclical diterpene. 209.
- the method of claim 209, wherein the terpene is a fusicoccadiene.
- the terpene synthase is a fusion terpene synthase. 213.
- the method of claim 212, wherein the fusion terpene synthase comprises a portion of a casbene synthase and a portion of a geranylgeranyl- diphosphate (GGPP) synthase.
- GGPP geranylgeranyl- diphosphate
- the polynucleotide further comprises a promoter for expression in the photo synthetic bacterium, yeast, alga, or vascular plant.
- a promoter for expression in the photo synthetic bacterium, yeast, alga, or vascular plant.
- the promoter is a constitutive promoter.
- the promoter is an inducible promoter.
- the inducible promoter is a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter. 219.
- the method of claim 215, wherein the promoter is T7, psbD, psdA, tufA, ltrA, atpA, or tubulin.
- the promoter is a chloroplast promoter. 221.
- the method of claim 215, wherein the promoter is psbA, psbD, atpA, or tufA. 222.
- the method of claim 193, wherein the polynucleotide further comprises a 5' regulatory region.
- 224 The method of claim 223, wherein said 5' regulatory region further comprises a promoter.
- said promoter is a constitutive promoter. 226.
- the method of claim 224, wherein said promoter is an inducible promoter.
- the method of claim 230 wherein the genome is a chloroplast genome of the alga or the vascular plant.
- the genome is a nuclear genome of the yeast, the alga, or the vascular plant.
- the photosynthetic bacterium is a member of genera Synechocystis, genera Synechococcus, or genera Athrospira. 234.
- the method of claim 193, wherein the photosynthetic bacterium is a cyanobacterium.
- the alga is a microalga. 236.
- the method of claim 193, wherein the alga is C. reinhardtii, D.
- alga is a cyanophyta, a prochlorophyta, a rhodophyta, a chlorophyta, a heteronochphyta, a tribophyta, a glaucophyta, a chlorarachniophyte, a euglenophyta, a euglenoid, a haptophyta, a chrysophyta, a cryptophyta, a cryptomonad, a dinophyta, a dinoflagellata, a pyrmnesiophyta, a bacillariophyta, a xanthophyta, a eust
- the polynucleotide further comprises a nucleic acid encoding a tag for purification or detection of the terpene synthase.
- the tag is a His-6 tag, a FLAG epitope, a c-myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- the tag is a His-6 tag, a FLAG epitope, a c-myc epitope, a Strep-TAGII, a biotin tag, a glutathione S-transferase (GST), a chitin binding protein (CBP), a maltose binding protein (MBP), or a metal affinity tag.
- GST glutathione S-transferase
- CBP chitin binding protein
- the polynucleotide further comprises a nucleic acid encoding an amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 12, SEQ ID NO: 19, SEQ ID NO: 23, or SEQ ID NO: 29. 241.
- the polynucleotide further comprises a nucleic acid encoding a selectable marker.
- the selectable marker is kanamycin, chloramphenicol, ampicillin, or glufosinate.
- the photosynthetic bacterium, yeast, alga, or vascular plant does not normally produce the terpene. 244.
- the method of claim 244, wherein the growing comprises supplying CO 2 to the organism. 246.
- the method of claim 245, wherein the CO 2 is at least partially derived from a burned fossil fuel. 247.
- the collecting step comprises one or more of the following steps: (a) harvesting the transformed organism; (b) harvesting the terpene from a medium comprising the transformed organism: (c) mechanically disrupting the transformed organism; or (d) chemically disrupting the transformed organism,
- Methods and compositions described herein utilize terpene/terpenoid synthases, such as fusicoccadiene synthase, for the production of terpenes and terpenoids, including fusicoccadiene, in various organisms. Methods are provided to create organisms genetically modified to produce terpenes and terpenoids. Production of terpenes and terpenoids or their derivatives are useful source of hydrocarbons which can be a source material for the production of fuel.
- terpene/terpenoid synthases such as fusicoccadiene synthase
- terpene synthases for example PaFS
- terpene synthases are engineered to be expressed in genetically modified host cells, for example, cyanobacteria, yeast and algae, where the syrifhaseCs) result in the production or increased production of terpenes and terpenoids, such as fusicoccadiene.
- the terpenes and terpenoids arc metabolically inactive in the host cell, leading to a build up of hydrocarbons.
- Such build up of hydrocarbons increases the usefulness of the engineered host cells for the purpose of fuel production.
- the hydrocarbons can be secreted from the host cell, cither naturally or by introduction of a terpene/terpenoid secretion protein.
- a vector comprising a nucleic acid encoding a terpene synthase, wherein the terpene synthase both condenses and/or cyclyz ⁇ s a terpene and wherein the nucleic acid is codon biased for expression in photosynthetic bacteria, yeast, algae or vascular plant.
- a vector described herein can contain a nucleic acid in which one or more codons are biased toward the usage of a target organism. Of various methods available for introducing codon bias to a gene, vectors described herein can contain a codon bias that is known as "hot' ' codon bias.
- a vector encodes a tcrpcnc synthase wherein the terpene synthase is fusicoccadiene synthase or a homolog thereof.
- the homolog has at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID. NO: 2.
- a vector can comprise a nucleic acid sequence, such as SEQ ID. IS! O: 4 or SEQ ID. NO: 7, both of which encode for a fusicoccadiene synthase.
- vectors described herein further comprise a promoter for expression in photosynthetic bacteria, non-photosynthetic bacteria, yeast or algae.
- a vector can utilize promoter sequences derived from, for example, T7 (bacteriophage T7), tD2 (truncated D2 promoter of Chlamydomonas), Dl (Chlamydomonas), psbD (Scenedesmus) or tufA (Scenedesmus).
- Other types of promoters contemplated in the present disclosure include promoters driving gene expression in a chloroplast or a nucleus of a host organism.
- a vector can include nucleic acid sequences which facilitate homologous recombination in a genome of an organism, such as a nuclear genome or a chloroplast genome, especially a microalgal chloroplast genome.
- Microalgal host organisms which can be transformed with the vectors of the present disclosure include Chlamydomonas reinhardtii, Dunaliella salina, Haematococcus pluvalis, Scenedesmus dimorphus, D. viridis, or D. tertiolecta.
- Organisms useful for the present disclosure include a photosynthetic bacterium, non-photosynthetic bacterium, yeast or alga.
- An example of the photosynthetic bacterium is a cyanobacterium, such as Synechocystis, Synechococcus, or Athrospira.
- Non-limiting examples of algal organisms are C.
- a terpene synthase can be a fusicoccadiene synthase.
- One of the products that may be produced in the genetically modified organism is fusicoccadiene, for example, fusicocca-2,10(14)-diene. In some instances, the fusicoccadiene is metabolically inactive in the genetically modified organism.
- a genetically modified organism of the present disclosure can be a photosynthetic baterium wherein the bacterium contains at least 0.25%, at least 0.5%, at least 0.75% or at least 1.0% dry weight as a fusicoccadiene.
- a genetically modified organism can also be an alga wherein the alga contains at least 0.05%, at least 0.1%, at least 0.25%, at least 0.5%, at least 0.75%, at least 1.0%, at least 1.25%, at least 1.5%, at least 1.75%, at least 2.0 %, at least 3.0%, at least 4.0% or at least 5.0% dry weight as fusicoccadiene.
- Exogenous or endogenous nucleic acids described herein can be present in the chloroplast and/or nucleus of an organism.
- one or more nucleic acids are integrated into a genome of the chloroplast.
- the chloroplast is homoplasmic for the nucleic acid.
- genetic modification of a host cell results in the host cell comprising sufficient chlorophyll levels for the organism to be photoautotrophic.
- Examples of the organisms useful for genetic modification described herein include cyanophyta, prochlorophyta, rhodophyta, chlorophyta, heterozziphyta, tribophyta, glaucophyta, chlorarachniophytes, euglenophyta, euglenoids, haptophyta, chrysophyta, cryptophyta, cryptomonads, dinophyta, dinoflagellata, pyrmnesiophyta, bacillariophyta, xanthophyta, eustigmatophyta, raphidophyta, phaeophyta, and phytoplankton.
- Some methods and compositions described herein are directed to a vector comprising a nucleic acid encoding an enzyme capable of modulating a fusicoccadiene biosynthetic pathway.
- a vector may further comprise a promoter for expression of the nucleic acid in bacteria, yeast or algae.
- Nucleic acid(s) included in such vectors may contain a codon biased form of a gene, optimized for expression in a host organism of choice. Such organisms can be a photosynthetic, a unicellular and/or eukaryotic.
- vectors described herein further comprise a nucleic acid encoding a tag for purification or detection of an enzyme, and a nucleic acid sequence for homologous recombination into a genome of a host cell.
- the target genome is a chloroplast genome.
- the target genome is a nuclear genome.
- the fusicoccadiene produced is fusicocca-2,10(14)- diene.
- Another aspect of the present disclosure is directed to a vector comprising a nucleic acid encoding an enzyme that produces a fusicoccadiene when the vector is integrated into a genome of an organism, such as photosynthetic bacteria, yeast or algae, wherein the organism does not produce fusicoccadiene without the vector and wherein the fusicoccadiene is metabolically inactive in the organism.
- each codon of the nucleic acid encoding the enzyme which is not a preferred codon of the organism is codon biased.
- a vector of the present disclosure can utilize "hot" codon bias or "regular" codon bias.
- a vector encoding an enzyme such as fusicoccadiene synthase or a homolog thereof may be modified by "hot" codon bias.
- a homolog useful in the present disclosure may have at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, or at least 99% sequence identity to, for example, the amino acid sequence of SEQ ID. NO: 2.
- a nucleic acid encoding an enzyme that produces fusicoccadiene can be a nucleic acid sequence disclosed herein, such as SEQ ID. NO: 4 or SEQ ID. NO: 7.
- a vector of the present disclosure may further comprise a promoter for expression in photosynthetic bacteria, yeast or algae, for example, a vector may include a T7, psaD, tubulin, tD2, Dl, psbD or tufA promoter.
- a promoter on a vector of the present disclosure may be a chloroplast promoter, such as tD2, Dl, psbD, or tufA.
- a vector can also include nucleic acid sequences known to facilitate homologous recombination in a genome of an organism, such as a chloroplast genome, especially a microalga 1 chloroplast genome.
- Sequences for homologous recombination can include sequences from a chloroplast genome of C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, or D. tertiolecta.
- genetically modified chloroplasts comprising any of the vectors of the present disclosure.
- non- vascular, photosynthetic organisms which comprise genetically modified chloroplasts of the present disclosure are disclosed.
- a non- vascular organism is an alga, including microalgae, such as C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D.
- the non- vascular, photosynthetic organisms can be a photosynthetic bacterium, such as a member of the genera Synechocystis, Synechococcus, or Athrospira.
- the non-vascular, photosynthetic organisms can be a photosynthetic bacterium, such as a member of the genera Synechocystis, Synechococcus, or Athrospira.
- a genetic modification can lead to the production of a fusicoccadiene that is not naturally produced by the organisms lacking the nucleic acid. In some instances a fusicoccadiene is metabolically inactive in the modified organism.
- Organisms useful for the present disclosure can be a unicellular organism, such as a cyanobacterium, yeast or alga.
- an exogenous nucleic acid encoding an enzyme is one that is specifically disclosed herein, such as SEQ ID NO: 44 and SEQ ID NO:46 (a nucleic acid sequence encoding the protein EAS27885 from Coccidioides immitis), SEQ ID NO: 49 and SEQ ID NO:51 (a nucleic acid sequence encoding the protein EAA68264 from Gibber -ellazeae), SEQ ID NO: 54 and SEQ ID NO:56 (a nucleic acid sequence encoding the protein ACLA 076850 from Aspergillus clavatus), or the nucleic acid sequence of SEQ ID NO: 4, or the nucleic acid sequence of SEQ ID NO: 7.
- a method of producing a fuel product comprising: a) transforming an organism, wherein the transformation results in the production or increased production of a fusicoccadiene; b) collecting the fusicoccadiene from the organism; and c) using the fusicoccadiene to produce a fuel product.
- the organism is an alga, including microalgae such as e C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D. tertiolecta.
- the organism can be a photosynthetic bacterium, such as a member of the genera Synechocystis, Synechococcus, or Athrospira.
- the organism can be a non-photosynthetic bacterium or yeast.
- a method provided herein further comprises growing the organism in an aqueous environment, wherein CO 2 is supplied to the organism.
- the CO 2 can be at least partially derived from a burned fossil fuel or flue gas.
- the collecting step of the method comprises one or more of the following steps: (a) harvesting the transformed organism; (b) harvesting the diterpene from a cell medium; (c) mechanically disrupting the organism; or (d) chemically disrupting the organism.
- Methods and compositions described herein are directed to a fuel product comprising a hydrocarbon refined from a fusicoccadiene.
- the fusicoccadiene is obtained from a microorganism, such bacteria, yeast, or algae. Such microorganisms can be photosynthetic.
- the fusicoccadiene is fusicocca-2,10(14) diene.
- a fuel product may further comprise a fuel additive.
- a method for identifying diterpene synthases with a desired trait comprises the steps of: a) performing one or more genetic manipulations on a nucleic acid encoding a diterpene synthase to produce a modified diterpene synthase; b) transforming the modified diterpene synthase into a microorganism; c) growing the microorganism to produce a diterpene; d) analyzing the diterpene; and e) identifying the transformed microorganism having the desired trait.
- Examples of a desired trait are the expression level of the diterpene synthase, the production level of the diterpene, or the species of diterpene produced. Genetic manipulations utilized in the method include look-through mutagenesis or walk-through mutagenesis.
- the organism is an alga, including microalgae such as e C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D. tertiolecta.
- the organism can be a photosynthetic bacterium, such as a member of the genera Synechocystis, Synechococcus, or Athrospira.
- a diterpene produced by a method disclosed herein can be cyclical, such as fusicoccadiene.
- Another aspect disclosed herein is a genetically modified organism comprising a nucleic acid encoding a diterpene synthase wherein the organism can grow in a high saline environment.
- the organism is a non-vascular, photosynthetic organism, for example D. salina.
- a high saline environment in some embodiments comprises 0.5-4.0 molar sodium chloride.
- a diterpene produced by these organisms can be cyclical, such as fusicoccadiene.
- a composition comprising at least 3% fusicoccadiene and at least a trace amount of a cellular portion of a genetically modified organism.
- the genetically modified organism can be modified by an exogenous or endogenous nucleic acid encoding fusicoccadiene synthase.
- a fusicoccadiene synthase gene is derived from Phomopsis amygdali.
- An organism for use in the present disclosure can be a bacterium or yeast.
- the bacterium is a photosynthetic bacterium, such as a member of the genera Synechocystis, Synechococcus, ox Athrospira.
- the organism is an alga, including microalgae, such as C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D. tertiolecta.
- a vector comprising: (a) a nucleic acid encoding protein EAS27885 from Coccidioides immitis, protein EAA68264 from Gibberella zeae, or protein EAQ85668 from Chaetomium blobosum, or a homolog thereof; and (b) a promoter configured for expression of the nucleic acid in a host cell.
- the host cell is a bacterium, yeast, or alga.
- a bacterium useful in some embodiments can be a photosynthetic bacterium, for example, members of the genera Synechocystis, Synechococcus, and Athrospira.
- Algae useful in some embodiments can be a microalga, such as C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D. tertiolecta.
- a promoter useful for some vectors of the present disclosure is a promoter capable of driving expression in chloroplast.
- a vector further comprises one or more nucleic acids which allow for homologous recombination with a genome of the host cell.
- a target genome is a chloroplast genome.
- Host cells suitable for the vector include cyanophyta, prochlorophyta, rhodophyta, chlorophyta, heterozziphyta, tribophyta, glaucophyta, chlorarachniophytes, euglenophyta, euglenoids, haptophyta, chrysophyta, cryptophyta, cryptomonads, dinophyta, dinoflagellata, pyrmnesiophyta, bacillariophyta, xanthophyta, eustigmatophyta, raphidophyta, phaeophyta, and phytoplankton.
- a vector disclosed herein may further comprise a nucleic acid encoding a tag for purification or detection of the enzyme and/or a selectable marker.
- a host cell comprising a vector comprising: (a) a nucleic acid encoding protein EAS27885 from Coccidioides immitis, protein EAA68264 from Gibberella zeae, or protein EAQ85668 from Chaetomium blobosum, or a homolog thereof; and (b) a promoter configured for expression of the nucleic acid in a host cell is provided.
- Host cells can include a bacterium, yeast, or alga.
- a bacterium can be a photosynthetic bacterium, for example, members of the genera Synechocystis, Synechococcus, and Athrospira. Examples of alga for use in the present disclosure include C.
- the vector, or a portion thereof is present in a chloroplast and can be integrated into a genome of a chloroplast.
- the host cell can be homoplasmic for the vector, or portion thereof.
- Figure 1 shows the isoprenoid pathway, and exemplary products of the pathway, for example, fusiccoca-2,10(14)-diene.
- Figure 2 shows the MEP pathway for the production of IPP and DMAPP.
- Figure 3 shows an overview of terpene biosynthesis in photosynthetic eukaryotes.
- Figure 4 shows exemplary terpenes biosynthesized by eukaryotes or prokaryotes.
- Figures 5A, B, and C show the genomic organization of exemplary plant terpenoid synthase genes.
- Figures 6A, B, and C show mass spectrum analysis containing peaks corresponding to fusicoccadiene and indole produced: in vivo by recombinant fusicoccadiene synthase expressed in E. coli ( Figure 6A); in vitro by isolated recombinant fusicoccadiene synthase expressed in E. coli ( Figure 6A).
- Figures 7A, B, and C show mass spectrum analysis containing peaks corresponding to fusicoccadiene produced by recombinant fusicoccadiene synthases encoded by genes with different codon biases expressed in C. reinhardtii.
- Figure 7A regular codon bias
- Figure 7B C. reinhardtii cells lacking the recombinant fusicoccadiene synthase gene
- Figure 7C "hot" codon bias.
- Figure 8 shows thin layer chromatogram of algal extracts demonstrating in vivo accumulation of fusicoccadiene.
- Figure 9 shows selection of six transformants of cyanobacterium clones transformed with PaFS.
- Figures 1OA and B show mass spectrum analysis containing peaks corresponding to fusicoccadiene produced by recombinant fusicoccadiene synthase expressed in cyanobacteria
- Figure 11 shows an SDS-PAGE gel showing production of fusicoccadiene synthase from a
- Figure 12 shows a GC/MSD total ion chromatogram analysis containing peaks corresponding to geranylgeraniol produced by a recombinant fusicoccadiene synthase C-terminal prenyltransferase domain expressed in E. coli, along with positive and negative controls.
- Figures 13A, B, and C show mass spectrum analysis containing peaks corresponding to fusicoccadiene produced by a recombinant fusicoccadiene synthase expressed in cyanobacteria
- Figures 14A and 14B are the total ion chromatogram and mass spectrum, respectively, demonstrating in vivo accumulation of ent-kaurene in Chlamydomonas transformed with recombinant ent-kaurene synthase.
- Figures 14C and 14D are the total ion chromatogram and mass spectrum, respectively, of untransformed Chlamydomonas, demonstrating that there is no accumulation of ent- kaurene.
- Figures 15A and 15B are the total ion chromatogram and mass spectrum, respectively, demonstrating in vivo accumulation of ent-kaurene in Scenedesmus transformed with recombinant ent- kaurene synthase.
- Figure 15C is the total ion chromatogram of untransformed Senedesmus, demonstrating that there is no accumulation of ent-kaurene.
- Figure 16 shows plant expression vector pEarleyGate 104.
- Figures 17A and 17B are the total ion chromatogram and mass spectrum, respectively, demonstrating in vivo accumulation of casbene in Chlamydomonas transformed with a recombinant fusion synthase.
- An endogenous nucleic acid, nucleotide, polypeptide, or protein as described herein is defined in relationship to the host organism.
- An endogenous nucleic acid, nucleotide, polypeptide, or protein is one that naturally occurs in the host organism.
- An exogenous nucleic acid, nucleotide, polypeptide, or protein as described herein is defined in relationship to the host organism.
- An exogenous nucleic acid, nucleotide, polypeptide, or protein is one that does not naturally occur in the host organism or is a different location in the host organism.
- the hydrocarbon chains are constructed one isoprene unit at a time by addition of the allylic moiety to the double bond in isopentenyl diphosphate, the fundamental five-carbon building block in the pathway, to form the next higher member of the series.
- Geranyl, farnesyl, and geranylgeranyl diphosphate lie at multiple branch points in the isoprenoid pathway and are substrates for many enzymes.
- the extensive family of isoprenoid compounds is synthesized from two-precursors, isopentenyl diphosphate and dimethylallyl disphosphate.
- the chain elongation and cyclization reactions of isoprenoid metabolism are electrophillic alkylations in which a new carbon-carbon single bond is formed by attaching a highly reactive electron-deficient carbocation to an electron-rich carbon-carbon double bond. From a chemical viewpoint, the most difficult step is generation of the carbocations.
- Nature has selected three strategies for catalysis: cleavage of the carbon-oxygen bond in an allylic disphosphate ester; protonation of a carbon-carbon double bond, or protonation of an epoxide.
- proteins from both classes that use allylic disphosphates as substrates contain highly conserved aspartate-rich DDXXD motifs (D is aspartate, X is any amino acid) thought to be Mg2+ binding sites.
- the cyclase domains of the three isoprenoid cyclases as well as farnesyl diphosphate synthase have a similar structural motif, consisting of 10 to 12 mostly antiparallel, alpha helices that form a large active site cavity (as described in Tarshis, L.C., Biochemistry, 33, 10871 (1994)). Lesburg, C. A., et al.
- the amino acid sequence of hopene synthase also contains a DDXXD motif.
- Pentalenene synthase and epi-aristolochene synthase also catalyze proton-promoted cyclizations (as described in for example, Sacchettini, J.C., and Poulter, CD, Science, Vol. 277, no. 5333, pp. 1788- 1789 (1997); and Starks, C M., et al., Science, Vol. 277, 1815 (1997)).
- Liquid fuels are primarily composed of mixtures of paraffmic and aromatic hydrocarbons.
- Terpenes are a class of biologically produced molecules synthesized from five carbon precursor molecules in a variety of organisms. Terpenes are pure hydrocarbons, while terpenoids may contain one or more oxygen atoms. Because they are hydrocarbons with a low oxygen content and contain no nitrogen or other heteroatoms, terpenes can be used as fuel components with minimal processing (as described, for example, in Calvin, M. (2008) "Fuel oils from euphorbs and other plants” Botanical Journal of the Linnean Society 94:97-110, and U.S. Patent No. 7,037,348).
- Terpenes are a subset of isoprenes. Terpenes are synthesized in biological systems from two five-carbon precursor molecules, isopentyl-diphosphate and dimethylallyldiphosphate (see Figure 2). The five-carbon precursors are produced through two pathways, the MEP and the mevalonic acid pathways (see Figure 2 and Figure 3). Through condensation reactions, the ten-, fifteen-, and twenty- precursor molecules geranyl diphosphate, farnesyl diphosphate, and geranylgeranyl diphosphate are produced by chain elongation enzymes.
- terpenoids are then cyclyzed by terpene synthases into monoterpenes (ClO molecules), sesquiterpenes (C 15 molecules), and diterpenes (C20 molecules).
- Farnesyl diphosphate can be condensed into C30 terpenes, and geranylgeranyl diphosphate can be condensed into C20, C40, or higher molecular weight terpenes.
- Figure 1 and Figure 3 provide an overview of terpenoid biosynthesis.
- FIG. 3 An overview of terpene biosynthesis in photosynthetic eukaryotes is shown in Figure 3. The intracellular compartmentalization of the mevalonate and mevalonate-independent pathways for the production of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), and of the derived terpenoids, is illustrated.
- the cytosolic pool of IPP which serves as a precursor of farnesyl diphosphate (FPP) and, ultimately, the sesquiterpenes and triterpenes, is derived from mevalonic acid (left).
- the plastidial pool of IPP is derived from the glycolytic intermediates pyruvate and glyceraldehyde-3-phosphate and provides the precursor of geranyl diphosphate (GPP) and geranylgeranyl disphosphate (GGPP) and, ultimately, the monoterpenes, diterpenes, and tetraterpenes (right). Reactions common to both pathways are enclosed by both boxes.
- GPP geranyl diphosphate
- GGPP geranylgeranyl disphosphate
- Reactions common to both pathways are enclosed by both boxes.
- Exemplary terpenes biosynthesized by eukaryotes or prokaryotes are shown in Figure 4.
- Monoterpenes, sesquiterpenes, and diterpenes are derived from the prenyl diphosphate substrates, geranyl diphosphate, farnesyl diphosphate, and geranylgeranyl disphosphate, respectively, and are produced in both angiosperms and gymnosperms.
- (-)-copalyl diphosphate and ent-kaurene are sequential intermediates in the biosynthesis of gibberellins plant growth hormones.
- Examples of terpenes that can be produced by an organism, for example, an alga, a yeast, a bacteria, or a higher plant, are Casbene, Ent-kaurene, Taxadiene, or Abietadiene (as shown in Figure 4).
- Fusieoecins or fusioeoccadienes are compounds which function in plant pathogenesis and are synthesized by the fungus Phomopsis amygdali.
- Fusiococcadiene is a cyclic diterpene formed by the condensation of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) to form the C 20 geranylgeranyl diphosphate (GGPP). This linear isoprenoid is then cyclized by a terpene cyclase (fusiococcadiene synthase) to form the tricyclic ring structure of fusiococca-2,10(14)-diene.
- IPP isopentenyl diphosphate
- DMAPP dimethylallyl diphosphate
- GGPP geranylgeranyl diphosphate
- This linear isoprenoid is then cyclized by a terpene cyclase (fusiococcadiene syntha
- fusiococca-2,10(14)-diene is carried out by a bifunctional enzyme fusicoccadiene synthase (PaFS), which has both a prenyltransferase domain for the formation of GGPP and a terpene cyclase domain for formation of the tricyclic ring fusicocca-2,10(14)-diene.
- PaFS fusicoccadiene synthase
- the carbon skeleton is then modified by oxidation, reduction, methylation, and glycosylation to form fusicoccin A and fusicoccin J, which function to assist plant pathogenesis by permanently activating plant 14-3-3 proteins.
- the present description provides methods and compositions for constructing genetically modified organisms which produce terpenes/terpenoids, including cyclical terpenes, such as fusicoccadiene, casbene, ent-kaurene, taxadiene, and abietadiene. Also provided are methods of producing terpenes/terpenoids (such as fusicoccadiene) in genetically modified organisms. In some aspects, the terpenes/terpenoids may be collected from the organism(s) which have been modified to produce them. Collected terpenes/terpenoids may then be further modified, for example by refining and/or cracking to produce fuel molecules or components.
- a host organism is transformed with a nucleic acid encoding at least one terpene/terpenoid synthase, such as fusicoccadiene synthase.
- Host organisms can include any suitable host, for example, a microorganism.
- Microorganisms which are useful for the methods described herein include, for example, photosynthetic bacteria (e.g., cyanobacteria), non-photosynthetic bacteria (e.g., E. col ⁇ ), yeast (e.g., Saccharomyces cerevisiae), and algae (e.g., microalgae such as Chlamydomonas reinhardti ⁇ ).
- Modified organisms are then grown, in some embodiments in the presence of CO 2 , to produce the terpene/terpenoid.
- the terpene/terpenoid is fusicoccene.
- Methods and compositions described herein may take advantage of naturally occurring product production pathways in an organism, for example, a photosynthetic organism. An example of one such production pathway is the isoprenoid biosynthetic pathway. Methods and compositions described herein may take advantage of naturally occurring biological molecules as substrates for the recombinantly expressed enzyme or enzymes of interest.
- IPP, DMAPP, FPP, and GPP may serve as substrates for enzymes of the present disclosure, and may be natively produced in bacteria, yeast, and algae (e.g., through the mevalonate pathway or the MEP pathway (see Figure 2 and Figure 3).
- Insertion of genes encoding an enzyme of the present disclosure into a host organism may lead to increased production of terpenes/terpenoids and/or derivatives, such as fusicoccadiene.
- fusicocca-2,10(14) diene is produced.
- Production of terpene/terpenoid derivatives may be artificially increased by introducing extra copies of an artificially engineered, exogenous enzyme modulating the isoprenoid biosynthetic pathway.
- Production of fusicoccadiene can be modulated by introducing a fusicoccadiene synthase, such as PaFS, or a homolog derived from bacteria, yeast, fungi, or an animal into an organism. Fusicoccadiene synthase homologs have been identified in Coccidioides immitis, Gibberella zeae, Alterna ⁇ a brassicicola, and Chaetomium blobosum, for example. Production of fusicoccadiene can also be modulated by introducing a portion of PaFS into an organism, wherein the portion exerts an enzymatic activity on a substrate.
- a fusicoccadiene synthase such as PaFS
- a homolog derived from bacteria, yeast, fungi or an animal into an organism. Fusicoccadiene synthase homologs have been identified in Coccidioides immitis, Gibberella zeae, Alterna ⁇ a brassicicola, and Chaetomium blobosum, for example.
- Enzymes with terpene cyclase activity can also be utilized in optimizing the production of a fusicoccadiene.
- enzymes capable of forming C 2 o geranylgeranyl diphosphate (GGPP) can be utilized in optimizing the production of a fusicoccadiene.
- GGPP C 2 o geranylgeranyl diphosphate
- a non-vascular photosynthetic microalga species can be genetically engineered to produce fusicoccadiene, such as C. reinhardtii, D. salina, H. pluvalis, S. dimorphus, D. viridis, and D. tertio ⁇ ecta.
- Production of fusicoccadiene in these microalgae can be achieved by engineering the microalgae to express an exogenous enzyme PaFS in the chloroplast or nucleus.
- PaFS can convert IPP and DMAPP into fusicocca-2,10(14)-diene.
- the expression of the PaFS can be accomplished by inserting an exogenous gene encoding PaFS into the chloroplast or nuclear genome of the microalgae.
- the modified strain of microalgae can be made homoplasmic to ensure that the PaFS gene will be stably maintained in the chloroplast genome of all descendents.
- a microalga is homoplasmic for a gene when the inserted gene is present in all copies of the chloroplast genome, for example.
- a chloroplast may contain multiple copies of its genome, and therefore, the term "homoplasmic” or “homoplasmy” refers to the state where all copies of a particular locus of interest are substantially identical. Plastid expression, in which genes are inserted by homologous recombination into all of the several thousand copies of the circular plastid genome present in each plant cell, takes advantage of the enormous copy number advantage over nuclear-expressed genes to permit expression levels that can readily exceed 10% or more of the total soluble plant protein.
- the process of determining the plasmic state of an organism of the present disclosure involves screening transformants for the presence of exogenous nucleic acids and the absence of wild-type nucleic acids at a given locus of interest.
- the present disclosure provides genetically modified microorganisms capable of producing useful products, for example, terpenes and terpenoids such as fusicoccadiene.
- useful products for example, terpenes and terpenoids such as fusicoccadiene.
- production of a desired terpene/terpenoid is achieved by way of expressing one or more codon biased terpene/terpenoid synthases in the microorganism.
- Examples of terpene/terpenoid synthases useful for the present disclosure are PaFS or PaFS homologs.
- EAS27885 from Coccidioides immitis
- a nucleic acid encoding protein EAA68264 from Gibber ell ⁇ ze ⁇ e
- a nucleic acid encoding protein EAQ85668 from Ch ⁇ etomium blobosum
- Nucleic acid sequences artificially modified to adopt "regular" codon bias or "hot” codon bias such as, for example, IS-87 ("regular” codon biased PaFS with a tag; SEQ ID NO: 4) or IS-88 ("hot” codon biased PaFS with a tag; SEQ ID NO: 7) can be utilized in the creation of genetically modified organisms useful for terpene/terpenoid (e.g., fusicoccadiene) production.
- Terpene synthases are also known as terpene cyclases, and these two terms can be used interchangeably throughout the disclosure.
- terpene cyclases use one of three substrates — the ten carbon geranyl diphosphate, fifteen carbon farnesyl diphosphate, or twenty carbon geranylgeranyl diphosphate, as substrates. Cyclases acting on geranyl diphosphate produce ten carbon monoterpenes; those that act on farnesyl diphosphate produce sesquiterpenes, and those that act on geranylgeranyl diphosphate produce diterpenes. Some naturally occurring terpene synthase (for instance, fusicoccadiene synthase from P.
- amygdal ⁇ contain both a terpene cyclase domain, as well as a prenyl transferase or chain elongation domain. If present, this chain elongation domain will produce the GPP, FPP, or GGPP substrate for the cyclase from the five carbon isoprenoids isoprenyl diphosphate and dimethylallyl diphosphate.
- fusicoccadiene synthase catalyzes two reactions, the first is a prenyl transferase reaction producing GGPP from three molecules of IPP and one molecule of DMAPP, and a second reaction where GGPP is cyclyzed to produce fusicocca- 2,10(14)diene and inorganic pyrophosphate. These two reactions reside in two separate domains of the protein; the N-terminal terpene cyclase and the C-terminal prenyl transferase domains.
- Terpenoids are the largest, most diverse class of natural products and they play numerous functional roles in primary metabolism.
- Terpenoids are present and abundant in all phyla, and they serve a multitude of functions in their internal environment (primary metabolism) and external environment (ecological interactions).
- the biosynthetic requirements for terpene production are the same for all organisms (a source of isopentenyl diphosphate, isopentyl diphosphate isomerase or other source of dimethylallyl diphosphate, prenyltransferases, and terpene synthases).
- terpenoids are of pharmacological significance, including the monoterpenoid (ClO) dietary anticarcinogen limonene (Crowell, P. L. and Gould, M. N. (1994) CRC Crit. Rev. Oncogenesis 5:1-22), the sequiterpenoid (C15) antimalaria artemisinin (Van Geldre, E., et al. (1997) Plant MoI. Biol. 33: 199-209), and the diterpenoid anticancer drug Taxol (Holmes, F. A. et al. (1995) Current status of clinical trials with paclitaxel and docetaxel, pp. 31-57 in Taxane Anticancer Agents: Basic Science and Current Status, edited by G. I. George, T. T. Chen, I. Ojima and D. M. Vyas. American Chemical Society Symposium Series 583, Washington D. C).
- All terpenoids are derived from isopentenyl disphosphate ( Figure 2).
- this central precursor is synthesized in the cytosol via the classical acetate/mevalonate pathway (for example, as described in Qureshi, N. and Porter, J. W. (1981) Conversion of acetyl-Coenzyme A to isopentenyl pyrophosphate, pp. 47-94 in Biosynthesis of Isoprenoid Compounds, Vol. 1, edited by J. W. Porter and S. L. Spurgeon, John Wiley & Sons, New York; and Newman, J. D. and Chappell, J. (1999) Crit. Rev. Biochem. MoI. Biol.
- terpene cyclases enzymes that are often referred to as terpene cyclases, since the products of the reactions are most often cyclic.
- terpenoid synthases of the monoterpene for example, as described in Croteau, R. (1987) Chem. Rev. 87: 929-954; and Wise, M. I. and Croteau, R. (1999) Monoterpene biosynthesis, pp. 97-153 in Comprehensive Natural Products Chemistry: Isoprenoids Including Steroids and Carotenoids, Vol. 2, edited by D. E. Cane, Pergamon, Oxford), sesquiterpene (for example, as described in Cane, D. E. (1990) Isoprenoid biosynthesis: overview, pp.
- the terpenoid synthases resemble the prenyltransferases; however, it is the tremendous range of possible variations in the carbocationic reactions (cyclizations, hydride shifts, rearrangements, and termination steps) catalyzed by the terpenoid synthases that sets them apart as a unique enzyme class. Indeed, it is these variations on a common mechanistic theme that permit the production of essentially all chemically feasible skeletal types, isomers, and derivatives that form the foundation for the great diversity of terpenoid structures.
- Tpsa sesquiterpene and diterpene synthases from angiosperms
- Tpsb monoterpene synthase from angiosperms of the Lamiaceae
- Tpsd 11 gymnosperm monoterpene, sesquiterpene, and diterpene synthases
- Tpsc tripeptide synthase
- Tpse tripeptide synthase
- the first two are diterpenes synthases involved in early steps of gibberellin biosynthesis (MacMillan, J. and Beale, M. (1999) Diterpene biosynthesis, pp. 217-243 in Comprehensive Natural Products Chemistry: Isoprenoids Including Steroids and Carotenoids, Vol. 2, edited by D. E. Cane, Pergamon, Oxford). These two Tps subfamilies are grouped into a single clade and are involved in primary metabolism, which suggests that the bifurcation of terpenoid synthases of primary and secondary metabolism occurred before the separation of angiosperms and gymnosperms (Bohlmann, J. G., et al. (1998) Proc. Natl. Acad. Sci.
- Genome organization (intron number, size, placement and phase, and exon size) of these gymnosperm terpene synthases was compared by Trapp, S.C. and Croteau, R. B. (Genetics (2001) 158:811-832) to eight previously characterized angiosperm terpene synthase genes and to six putative terpene synthase genomic sequences from Arabidopsis thaliana.
- terpene synthase genes Three distinct classes of terpene synthase genes were discerned, from which assumed patterns of sequential intron loss and the loss of an unusual internal sequence element suggest that the ancestral terpenoid synthase gene resembled a contemporary conifer diterpene synthase gene in containing at least 12 introns and 13 exons of conserved size.
- This selection of genes represents constitutive and inducible terpenoid synthases from each class (monoterpene, sesquiterpene, and diterpene). Sequence alignment of each cDNA with the corresponding gDNA, including putative terpene synthases from Arabidopsis, established exon and intron boundaries, exon and intron sizes, and intron placement; generic dicot plant 5'- and 3 '-splice site consensus sequences (5' NAGT GTAAGWWWW; and 3'YAGT) were used to define specific boundaries (Hanley, B. A. and Schuler, M. A. (1988) Nucleic Acid Res. 16:7159-7176; and Turner, G. (1993) Gene organization in filamentous fungi, pp.
- Tc genomic sequences by Trapp, S.C. and Croteau, R. B. (Genetics (2001) 158:811-832); NA, sequences unavailable in the public databases but disclosed in journal reference; pc, sequences obtained by personal communications; ds, sequences in public database by direct submission but not published; p, sequences in database with putative function; c, confirmed gene by experimental determination stated in database; i, two possible isozymes reported for the same region referred to as Al and A2; — , no former gene name or accession number.
- Species names are: Abies grandis, Arabidopsis thaliana, Clarkia concinna, Gossypium arboreum, Hyoscyamus muticus, Mentha longifolia, Mentha spicata, Nicotiana tabacum, Ricinus communis, Perillafrutescens, Taxus brevifolia, and Zea mays.
- b Nomenclature architecture is specified as follows.
- the Latin binomial two-letter abbreviations are in spaces 1 and 2.
- the substrates (1- to 4-letter abbreviations) are in spaces 3-6, consisting of 1- or 2-letter abbreviations for substrate utilized in boldface ⁇ e.g. , g, geranyl diphosphate; f, faraesyl diphosphate; gg, geranylgeranyl diphosphate; c, copalyl diphosphate; ch, chrysanthemyl diphosphate; in lowercase) followed by stereochemistry and/or isomer definition (e.g., a, b, d, g, etc.
- Tbggt ⁇ x cDNA and gTbggt ⁇ x e.g., Tbggt ⁇ x cDNA and gTbggt ⁇ x, or Tbggt ⁇ x gene (nomenclature system devised by S. Trapp, E. Davis, J. Crock, and R. Croteau, and as discussed in Trapp, S.C. and Croteau, R. B., Genetics (2001) 158:811-832).
- a comparison of genomic structures indicate that the plant terpene synthase genes consist of three classes based on intron/exon pattern; 12-14 introns (class I), 9 introns (class II), or 6 introns (class III). Using this classification, based on distinctive exon/intron patterns, seven conifer genes that Trapp, S.C. and Croteau, R. B. (Genetics (2001) 158:811-832) studied were assigned to class I or class II.
- Class I comprises conifer diterpene synthase genes Aggg ⁇ bi and Tbggt ⁇ x and sesquiterpene synthase Agf ⁇ bis and angiosperm synthase genes specifically involved in primary metabolism (Atgg-coppl and Ccglinoh).
- Terpene synthase class I genes contain 11-14 introns and 12-15 of exons of characteristic size, including the CDIS domain comprising exons 4, 5, and 6 and the first approximately 20 amino acids of exon 7, and introns 4, 5, and 6 (this unusual sequence element corresponds to a 215-amino-acid region (Pro 137 - Leu 351) of the Aggg ⁇ bi sequence).
- Class II Tps genes comprise only conifer monoterpene and sesquiterpene synthases, and these contain 9 introns and 10 exons; introns 1 and 2 and the entire CDIS element have been lost, including introns 4, 5 and 6.
- Class III Tps genes comprise only angiosperm monoterpene, sesquiterpene, and diterpene synthases involved in secondary metabolism, and they contain 6 introns and 7 exons. Introns 1, 2, 7, 9, and 10, and the CDIS domain have been lost in the class III type.
- the introns of class III Tps genes (introns 3, 8, and 11-14) are conserved among all plant terpene synthase genes and were described as introns 1-6, respectively, in previous analyses (Mau, C.
- a number of diterpene products may be produced in vivo by inserting an exogenous or endogenous gene encoding a diterpene synthase into the chloroplast or nuclear genome of an organism, for example, a microalgae, yeast, or plant.
- the exogenous or endogenous enzyme will utilize either the endogenous geranylgeranyl diphosphate as a substrate, or if the exogenous or endogenous enzyme contains a GGPP synthase domain, will utilize the endogenous IPP and DMAPP as substrates.
- the enzyme will convert the substrates to a diterpene in vivo.
- diterpene synthases examples include Abietadiene synthase, Taxadiene synthase, Casbene synthase, and ent-Kaurene synthase.
- Trapp, S. C, and Croteau R. B. Genetics 158:811-832 (2001) studied the genomic organization of plant terpene synthase (Tps) genes and the results of their studies are shown in Figures 5A, B, and C. Black vertical bars represent introns 1-14 (Roman numerals in figure) and are separated by shaded blocks with specified lengths, representing exons 1-15.
- the terpenoid synthase genes are divided into three classes (class I, class II, and class III), which appear to have evolved sequentially from class I to class III by intron loss and loss of the conifer diterpene internal sequence domain (CDIS).
- Class I Tps genes comprise 12-14 introns and 13-15 exons and consist primarily of diterpene synthases found in gymnosperms (secondary metabolism) and angiosperms (primary metabolism).
- Class II Tps genes comprise 9 introns and 10 exons and consist of only gymnosperm monoterpene and sesquiterpene synthases involved in secondary metabolism.
- Class III Tps genes comprise 6 introns and 7 exons and consist of angiosperm monoterpene, sesquiterpene, and diterpene synthases involved in secondary metabolism. Exons that are identically shaded illustrate sequential loss of introns and the CDIS domain, over evolutionary time, from class I through class III.
- the methionine at the translational start site of the coding region (and alternatives), highly conserved histidines, and single or double arginines indicating the minimum mature protein are represented by M, H, RR, or RX (X representing other amino acids that are sometimes substituted), respectively.
- the enzymatic classification as a monoterpene, sesquiterpene, or diterpene synthase is represented by ClO, C 15, C20, respectively.
- Conifer terpene synthases were isolated and sequenced to determine genomic structure; all other terpene synthase sequences were obtained from public databases or by personal communication (see Table 1).
- Putative terpene synthases are referred to as putative proteins and are illustrated based upon predicted homology. Two different predictions of the same putative protein (accession no. Z97341) are shown as limonene synthase Al and A2; if Al is correct, the genomic pattern suggests that AtHm (accession no.
- Z97341 is a sesquiterpene synthase; if A2 is correct, then AtHm (accession no. Z97341) is a monoterpene synthase.
- intron borders of the Msg-lim/ MIg-lim chimera and Hmfvetl genes see Table 1
- the intron/exon borders predicted for a number of terpene synthases identified in the Arabidopsis database were determined to be incorrect; these data were reanalyzed and new predictions used.
- the number in parentheses represents the deduced size (in amino acid residues) of the corresponding protein or preprotein, as appropriate.
- Table 1 provides the names of various terpene synthases and provides the GenBank accession numbers for both the cDNA and gDNA of many of the listed terpene synthases. A listing of the articles cited in Table 1 is provided below.
- additional exemplary terpene synthases include Bisobolene synthase, (-)-Pinene synthase, ⁇ -Selinene synthase, (-)-Limonene synthase, Abeitadiene synthase, and Taxadiene synthase.
- synthases include, but are not limited to, botryococcene synthase, limonene synthase, 1,8 cineole synthase, ⁇ -pinene synthase, camphene synthase, (+)-sabinene synthase, myrcene synthase, abietadiene synthase, taxadiene synthase, farnesyl pyrophosphate synthase, amorphadiene synthase, (E)- ⁇ -bisabolene synthase, diapophytoene synthase, or diapophytoene desaturase. Additional examples of enzymes useful in the disclosed embodiments are described in Table 2.
- the synthase may also be ⁇ -caryophyllene synthase, germacrene A synthase, 8-epicedrol synthase, valencene synthase, (+)- ⁇ -cadinene synthase, germacrene C synthase, (E)- ⁇ -farnesene synthase, casbene synthase, vetispiradiene synthase, 5-epi-aristolochene synthase, aristolchene synthase, ⁇ -humulene, (E,E)- ⁇ -farnesene synthase, (- )- ⁇ -pinene synthase, limonene cyclase, linalool synthase, (+)-bornyl diphosphate synthase, levopimaradiene synthase, isopimaradiene synthase, (E)- ⁇ -bisabolene synthase, copa
- the vectors and other nucleic acids disclosed herein can encode polypeptide(s) that promote the production of intermediates, products, precursors, and derivatives of the products (e.g., terpenes and terpenoids) described herein.
- the vectors can encode polypeptide(s) that promote the production of intermediates, products, precursors, and derivatives in the isoprenoid pathway.
- the enzymes utilized in practicing the present disclosure may be encoded by nucleotide sequences derived from any organism, including bacteria, plants, fungi and animals. In some instances, the enzymes are terpene synthases.
- a "terpene synthase” is a naturally or non-naturally occurring enzyme which produces or increases production of terpene/terpenoids and/or their derivatives.
- Terpenes/terpenoids of the present disclosure can be monoterpenes, diterpenes, triterpenes, sesquiterpenes, or any other naturally or non-naturally occurring terpene.
- the terpene is fusicoccadiene.
- a terpene synthase of the present disclosure is fusicoccadiene synthase, producing fusicoccadiene.
- a terpene synthase of the present disclosure catalyzes the conversion of IPP and/or DMAPP into a terpene/terpenoid of interest, such as fusicoccadiene.
- the enzymes may have one or more distinct catalytic activities, such as prenyltransferase activity and/or terpene cyclase activity.
- a host cell may be genetically modified so as to produce more than one exogenous or endogenous polypeptide (e.g., enzyme) which, in combination results in the production of a desired product (e.g., terpene/terpenoid).
- the polypeptides may be naturally occurring polypeptides.
- polypeptides and/or the genes encoding them may be modified from their natural state, including, but not limited to functional truncations, genetic modifications, or synthetically synthesized polynucleotides.
- Polynucleotides encoding enzymes and other proteins useful in the present disclosure may be isolated and/or synthesized by any means known in the art, including, but not limited to cloning, sub-cloning, and PCR. Exemplary DNA manipulations are described in Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998.
- An expression vector including, but not limited to, regulatory elements and sequences encoding genes, may comprise nucleotide sequences that are codon biased for expression in the organism being transformed. Therefore, when synthesizing, for example, a gene for expression in a host cell, it may be desirable to design the gene such that its frequency of codon usage approaches the frequency of the preferred codon usage of the host cell. In some instances, a native (unmodified) gene may exhibit a complete or partial match to the codon bias of the intended target host cell. In such instances, little or no codon optimization need be performed.
- codon bias differs between the nuclear genome and organelle genomes, thus, codon optimization or biasing may be performed for the target genome (e.g., nuclear codon biased or chloroplast codon biased).
- the codons of the host organism may be, for example, A/T rich in the third nucleotide position. Often, A/T rich codon bias is used for algae.
- at least 50% of the third nucleotide position of the codons are A or T.
- at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 99% of the third nucleotide position of the codons are A or T.
- Codons of an encoding polynucleotide can be biased to reflect chloroplast and/or nuclear codon usage. Most amino acids are encoded by two or more different (degenerate) codons, and it is well recognized that various organisms utilize certain codons in preference to others. Such preferential codon usage, which also is utilized in chloroplasts, is referred to herein as "chloroplast codon usage”. The codon bias of Chlamydomonas reinhardtii has been reported. See U.S. Application 2004/0014174. Percent identity to the native sequence (in the organism from which the sequence was isolated) may be about 50%, about 60%, about 70%, about 80%, about 90%, about 95%, about 99% or higher.
- bias when used in reference to a codon, means that the sequence of a codon in a polynucleotide has been changed such that the codon is one that is used preferentially in the target which the bias is for, e.g., alga cells, or chloroplasts.
- a polynucleotide that is biased for chloroplast codon usage can be synthesized de novo, or can be genetically modified using routine recombinant DNA techniques, for example, by a site-directed mutagenesis method, to change one or more codons such that they are biased for chloroplast codon usage.
- Chloroplast codon bias can be variously skewed in different plants, including, for example, in alga chloroplasts as compared to tobacco.
- the chloroplast codon bias selected reflects chloroplast codon usage of the plant which is being transformed with the nucleic acids of the present disclosure.
- the chloroplast codon usage is biased to reflect alga chloroplast codon usage
- “hot” codon bias or “regular” codon bias are used broadly here to refer to different types of artificially introduced codon bias to a gene.
- Regular codon bias refers to a codon bias closely following the codon usage of the host organism into which the gene is introduced. Such regular codon bias can involve the alteration of one or more codons from the native sequence to a codon preferred in a host organism. In some instances, a host organism will have different codon usages in different genomes. For example, the chloroplast genome of C. reinhardtii has a different codon bias than the nuclear genome. Therefore, codon biasing typically will reflect the targeted genome within the host cell.
- “Hot” codon bias is similar to regular codon bias in that one or more codons from a native sequence are changed to reflect codon usage in the host organism.
- the synthetic gene contains the codon most frequently used by the host genome to encode the desired amino acid at that position, unless use of that codon would introduce an undesired restriction enzyme recognition sequence at a given position. For instance, there are three codons that encode the amino acid isoleucine, ATC, ATT, and ATA. In the Chlamydomonas chloroplast genome, the codon ATT is used
- SEQ ID NO: 1 Phomopsis amygdali fusicoccadiene synthase (PaFS) nucleotide sequence
- SEQ ID NO:3 Strep-Tag amino acid sequence including TG linker
- SEQ ID NO:4 "Regular” codon optimized PaFS nucleotide sequence without tag
- SEQ ID NO:5 "Regular” codon optimized PaFS nucleotide sequence with C- terminal Strep Tag
- SEQ ID NO: 10 Ent-Kaurene synthase protein sequence
- SEQ ID NO: 11 "Hot” codon optimized ent-Kaurene synthase nucleic acid sequence, without tag
- SEQ ID NO: 13 "Hot” codon optimized ent-Kaurene synthase nucleic acid sequence with N-terminal FLAG tag
- SEQ ID NO: 14 Amino acid sequence of ent-Kaurene synthase with N-terminal
- SEQ ID NO: 15 Ricinus communis casbene synthase nucleotide sequence
- SEQ ID NO: 16 Casbene synthase protein sequence
- SEQ ID NO: 17 "Hot” codon optimized casbene synthase nucleic acid sequence, without tag
- SEQ ID NO: 18 Hot" codon optimized casbene synthase nucleic acid sequence, with C-terminal strep tag including TGIN linker
- SEQ ID NO: 19 Strep tag amino acid sequence including TGIN linker
- SEQ ID NO:20 Casbene synthase protein sequence with strep-tag
- SEQ ID NO:21 Casbene synthase/GGPP synthase fusion protein nucleotide sequence, without tag
- SEQ ID NO:23 CLIP-8x his tag protein sequence
- SEQ ID NO:24 Casbene synthase/GGPP synthase fusion protein nucleotide sequence including CLIP-8x his tag
- SEQ ID NO:25 Casbene synthase/GGPP synthase fusion protein sequence including CLIP-8x his tag
- SEQ ID NO:26 Abies grandis Abietadiene synthase gene nucleotide sequence
- SEQ ID NO:31 Abietadiene synthase nucleotide sequence with C-terminal TEV-
- SEQ ID NO:34 Codon optimized taxadiene synthase nucleotide sequence without tag
- SEQ ID NO:35 Codon optimized taxadiene synthase nucleotide sequence with C- terminal TEV-FLAG tag protein sequ ieennccee
- SEQ ID NO:36 Taxadiene synthase nucleotide sequence with C-terminal TEV-
- SEQ ID NO:37 Prenyltransferase domain of fusicoccadiene synthase nucleotide sequence
- SEQ ID NO:38 Prenyltransferase domain of fusicoccadiene synthase protein sequence
- SEQ ID NO:39 "Hot" codon optimized prenyltransferase domain of fusicoccadiene synthase nucleotide sequence without tag
- SEQ ID NO:40 "Hot” codon optimized prenyltransferase domain of fusicoccadiene synthase nucleotide sequence with C-terminal Strep Tag
- SEQ ID NO:41 Prenyltransferase domain of fusicoccadiene synthase with C- terminal Strep Tag protein sequence
- SEQ ID NO:42 Primer 1 from Example 12
- SEQ ID NO:44 Native nucleotide sequence encoding a hypothetical protein
- SEQ ID NO:47 C immitis hypothetical protein nucleotide sequence as expressed
- SEQ ID NO:48 C. immitis hypothetical protein translation as expressed (IS-92) with C-terminal strep tag
- SEQ ID NO:49 Nucleotide sequence Encoding a hypothetical protein EAA68264 from G. zeae
- SEQ ID NO:51 Codon optimized gene encoding hypothetical protein EAA68264 from G. zeae without tag
- SEQ ID NO:52 Codon optimized gene encoding hypothetical protein EAA68264 from G. zeae nucleotide sequence as expressed with c-terminal strep tag
- SEQ ID NO: 54 Nucleotide sequence from Aspergillus clavatus NRRLl encoding hypothetical protein ACLA_076850
- SEQ ID NO:58 Translation of Codon optimized nucleotide sequence for hypothetical protein ACLA_076850 as expressed, with c-terminal strep-tag
- SEQ ID NO:59 Primer 1 from Example 13
- BLAST algorithm One example of an algorithm that is suitable for determining percent sequence identity or sequence similarity between nucleic acid or polypeptide sequences is the BLAST algorithm, which is described, e.g., in Altschul et al, J. MoI. Biol. 215:403-410 (1990).
- Software for performing BLAST analysis is publicly available through the National Center for Biotechnology Information.
- the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
- the BLASTP program uses as defaults a word length (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (as described, for example, in Henikoff & Henikoff (1989) Proc. Natl. Acad. ScL USA, 89: 10915).
- W word length
- E expectation
- BLOSUM62 scoring matrix as described, for example, in Henikoff & Henikoff (1989) Proc. Natl. Acad. ScL USA, 89: 10915.
- the BLAST algorithm also can perform a statistical analysis of the similarity between two sequences (for example, as described in Karlin & Altschul, Proc. Natl Acad. ScL USA, 90:5873-5787 (1993)).
- BLAST algorithm One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
- P(N) the smallest sum probability
- a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.1, less than about 0.01, or less than about 0.001.
- a polynucleotide or nucleic acid of the present disclosure can encode more than one gene.
- the polynucleotide can encode for a first gene and a second gene, or a first gene, a second gene, and a third gene.
- any or all of the genes can be the same or different.
- the polypeptides expressed in host cells of the present disclosure including yeast, bacteria, or a microalga such as C. reinhardtii may be assembled to form functional polypeptides and protein complexes.
- a polynucleotide or nucleic acid molecule as described herein can contain two or more sequences that are linked in a manner such that the product is not found in a cell in nature.
- the two or more nucleotide sequences can be operatively linked and, for example, can encode a fusion polypeptide, or can comprise an encoding nucleotide sequence and a regulatory element.
- a nucleic acid molecule also can be based on, but manipulated so as to be different from a naturally occurring polynucleotide, (e.g. biased for chloroplast codon usage or a restriction enzyme site can be inserted into the nucleic acid).
- a nucleic acid molecule may further contain a peptide tag (e.g., His-6 tag), which can facilitate identification of expression of the polypeptide in a cell. Additional tags include, for example: a FLAG epitope; a c-myc epitope; Strep-TAGII; biotin; and glutathione S-transferase. Such tags can be detected by any method known in the art (e.g., anti-tag antibodies or streptavidin).
- Such tags may also be used to isolate the operatively linked polypeptide(s), for example by affinity chromatography.
- a polynucleotide or nucleic acid sequence comprising naturally occurring nucleotides and phosphodiester bonds can be chemically synthesized or can be produced using recombinant DNA methods, using an appropriate polynucleotide as a template.
- a polynucleotide comprising nucleotide analogs or covalent bonds other than phosphodiester bonds generally are chemically synthesized, although an enzyme such as T7 polymerase can incorporate certain types of nucleotide analogs into a polynucleotide and, therefore, can be used to produce such a polynucleotide recombinantly from an appropriate template (for example, as described in Jellinek et al., Biochemistry 34: 11363-11372, 1995).
- Polynucleotides or nucleic acids useful for practicing the present disclosure may be isolated from any organism.
- Examples of products contemplated herein include hydrocarbon products and hydrocarbon derivative products.
- a hydrocarbon product is one that consists of only hydrogen molecules and carbon molecules.
- a hydrocarbon derivative product is a hydrocarbon product with one or more heteroatoms, wherein the heteroatom is any atom that is not hydrogen or carbon. Examples of heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorus.
- Some products can be hydrocarbon-rich, wherein, for example, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 95% of the product by weight is made up of carbon and hydrogen.
- One exemplary group of hydrocarbon products are isoprenoids.
- Isoprenoids are derived from isoprene subunits, but are modified, for example, by the addition of heteroatoms such as oxygen, by carbon skeleton rearrangement, and by alkylation. Isoprenoids generally have a number of carbon atoms which is evenly divisible by five, but this is not a requirement as "irregular" terpenoids are known to one of skill in the art. Carotenoids, such as carotenes and xanthophylls, are examples of isoprenoids that are useful products. A steroid is an example of a terpenoid.
- isoprenoids examples include, but are not limited to, hemiterpenes (C5), monoterpenes (ClO), sesquiterpenes (C 15), diterpenes (C20), triterpenes (C30), tetraterpenes (C40), polyterpenes (C n , wherein "n” is equal to or greater than 45), and their derivatives.
- isoprenoids include, but are not limited to, limonene, 1,8-cineole, ⁇ -pinene, camphene, (+)-sabinene, myrcene, abietadiene, taxadiene, farnesyl pyrophosphate, fusicoccadiene, amorphadiene, (E)- ⁇ -bisabolene, zingiberene, or diapophytoene, and their derivatives.
- Useful products include, but are not limited to, terpenes and terpenoids as described above.
- An exemplary group of terpenes are diterpenes (C20).
- Diterpenes are hydrocarbons that can be modified (e.g. oxidized, methyl groups removed, or cyclized); the carbon skeleton of a diterpene can be rearranged, to form, for example, terpenoids, such as fusicoccadiene. Fusicoccadiene may also be formed, for example, directly from the isoprene precursors, without being bound by the availability of diterpene or GGDP.
- Genetic modification of organisms, such as algae, by the methods described herein, can lead to the production of fusicoccadiene, for example, and other types of terpenes, such as limonene, for example. Genetic modification can also lead to the production of modified terpenes, such as methyl squalene or hydroxylated and/or conjugated terpenes such as paclitaxel.
- Other useful products can be, for example, a product comprising a hydrocarbon obtained from an organism expressing a diterpene synthase.
- Such exemplary products include ent-kaurene, casbene, and fusicocaccadiene, and may also include fuel additives.
- the products produced by the present disclosure may be naturally, or non-naturally (e.g., as a result of transformation) produced by the host cell(s) and/or organism(s) transformed.
- products not naturally produced by algae may include non-native terpenes/terpenoids such as fusicoccadiene.
- the host cell may be genetically modified, for example, by transformation of the cell with a sequence encoding a protein, wherein expression of the protein results in the secretion of a non- naturally produced product or products.
- Examples of useful products include petrochemical products and their precursors and all other substances that may be useful in the petrochemical industry.
- Products include, for example, petroleum products, precursors of petroleum, as well as petrochemicals and precursors thereof.
- the fuel or fuel products may be used in a combustor such as a boiler, kiln, dryer or furnace.
- Other examples of combustors are internal combustion engines such as vehicle engines or generators, including gasoline engines, diesel engines, jet engines, and other types of engines. Products described herein may also be used to produce plastics, resins, fibers, elastomers, pharmacuticals, neutraceuticals, lubricants, and gels, for example.
- Isoprenoid precursors are generated by one of two pathways; the mevalonate pathway or the methylerythritol phosphate (MEP) pathway ( Figure 2 and Figure 3). Both pathways generate dimethylallyl pyrophosphate (DMAPP) and isopentyl pyrophosphate (IPP), the common C5 precursor for isoprenoids.
- DMAPP dimethylallyl pyrophosphate
- IPP isopentyl pyrophosphate
- the DMAPP and IPP are condensed to form geranyl-diphosphate (GPP), or other precursors, such as farnesyl-diphosphate (FPP) or geranylgeranyl-diphosphate (GGPP), from which higher isoprenoids are formed.
- GPP geranyl-diphosphate
- FPP farnesyl-diphosphate
- GGPP geranylgeranyl-diphosphate
- Useful products can also include small alkanes (for example, 1 to approximately 4 carbons) such as methane, ethane, propane, or butane, which may be used for heating (such as in cooking) or making plastics.
- Products may also include molecules with a carbon backbone of approximately 5 to approximately 9 carbon atoms, such as naptha or ligroin, or their precursors.
- Other products may be about 5 to about 12 carbon atoms, or cycloalkanes used as gasoline or motor fuel.
- Molecules and aromatics of approximately 10 to approximately 18 carbons, such as kerosene, or its precursors, may also be useful as products.
- Products include lubricating oil, heavy gas oil, or fuel oil, or their precursors, and can contain alkanes, cycloalkanes, or aromatics of approximately 12 to approximately 70 carbons. Products also include other residuals that can be derived from or found in crude oil, such as coke, asphalt, tar, and waxes, generally containing multiple rings with about 70 or more carbons, and their precursors.
- the various products may be further refined to a final product for an end user by a number of processes.
- Refining can, for example, occur by fractional distillation.
- a mixture of products such as a mix of different hydrocarbons with various chain lengths may be separated into various components by fractional distillation.
- Refining may also include any one or more of the following steps, cracking, unifying, or altering the product.
- Large products such as large hydrocarbons (e.g. > ClO) may be broken down into smaller fragments by cracking. Cracking may be performed by heat or high pressure, such as by steam, visbreaking, or coking. Products may also be refined by visbreaking, for example by thermally cracking large hydrocarbon molecules in the product by heating the product in a furnace.
- Refining may also include coking, wherein a heavy, almost pure carbon residue is produced.
- Cracking may also be performed by catalytic means to enhance the rate of the cracking reaction by using catalysts such as, but not limited to, zeolite, aluminum hydrosilicate, bauxite, or silica-alumina.
- Catalysis may be by fluid catalytic cracking, whereby a hot catalyst, such as zeolite, is used to catalyze cracking reactions.
- Catalysis may also be performed by hydrocracking, where lower temperatures are generally used in comparison to fluid catalytic cracking. Hydrocracking can occur in the presence of elevated partial pressure of hydrogen gas. Products may be refined by catalytic cracking to generate diesel, gasoline, and/or kerosene.
- the products may also be refined by combining them in a unification step, for example by using catalysts, such as platinum or a platinum-rhenium mix.
- the unification process can produce hydrogen gas, a by-product, which may be used in cracking.
- the products may also be refined by altering, rearranging, or restructuring hydrocarbons into smaller molecules.
- catalytic reforming processes There are a number of chemical reactions that occur in catalytic reforming processes which are known to one of ordinary skill in the arts. Catalytic reforming can be performed in the presence of a catalyst and a high partial pressure of hydrogen. One common process is alkylation.
- propylene and butylene are mixed with a catalyst such as hydrofluoric acid or sulfuric acid, and the resulting products are high octane hydrocarbons, which can be used to reduce knocking in gasoline blends.
- a catalyst such as hydrofluoric acid or sulfuric acid
- the products may also be blended or combined into mixtures to obtain an end product.
- the products may be blended to form gasoline of various grades, gasoline with or without additives, lubricating oils of various weights and grades, kerosene of various grades, jet fuel, diesel fuel, heating oil, and chemicals for making plastics and other polymers.
- Compositions of the products described herein may be combined or blended with fuel products produced by other means.
- a molecule may not exist in conventional petrochemicals or refining, it may still be useful in these industries.
- a hydrocarbon could be produced that is in the boiling point range of gasoline, and that could be used as gasoline or an additive, even though the hydrocarbon does not normally occur in gasoline.
- the organisms/host cells herein can be transformed to modify the production and/or secretion of a product(s) with an expression vector, or a linearized portion thereof, for example, to increase production and/or secretion of a product(s).
- the product(s) can be naturally or not naturally produced by the organism.
- An expression vector, or a linearized portion thereof, can comprise one or more polynucleotides that comprise nucleotide sequences that are exogenous or endogenous to the host organism.
- flanking sequences include those that have at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or 100% sequence identity to the sequence found in the host cell.
- the flanking homologous sequences enable recombination of the exogenous or endogenous sequence into the genome of the host organism through homologous recombination.
- the flanking homologous sequences can be at least 100, at least 200, at least 300, at least 400, at least 500, at least 1000, or at least 1500 nucleotides in length.
- Any of the vectors described herein can further comprise a regulatory control sequence.
- a regulatory control sequence may include, for example, promoter(s), operator(s), repressor(s), enhancer(s), transcription termination sequence(s), sequence(s) that regulate translation, or other regulatory control sequence(s) that are compatible with the host cell and control the expression of the nucleic acid molecules of the present disclosure.
- a regulatory control sequence includes transcription control sequence(s) that are able to control, modulate, or effect the initiation, elongation, and/or termination of transcription.
- a regulatory control sequence can increase the transcription and/or translation rate and/or efficiency of a gene or gene product in an organism, wherein expression of the gene or gene product is upregulated resulting (directly or indirectly) in the increased production, secretion, or both, of a product described herein.
- the regulatory control sequence may also result in increased of production, secretion, or both, of a product by increasing the stability of a gene or gene product.
- a regulatory control sequence can be exogenous or endogenous in relationship to the host organism.
- a regulatory control sequence may encode one or more polypeptides that are enzymes that promote expression and production of a desired product.
- an exogenous regulatory control sequence may be derived from another species of the same genus of the organism (e.g., another algal species).
- Regulatory control sequences that can be used in the disclosed embodiments can effect inducible or constitutive expression of a desired sequence.
- algal regulatory control sequences can be used; these sequences can be of nuclear, viral, extrachromosomal, mitochondrial, or chloroplastic origin.
- Suitable regulatory control sequences include those naturally associated with the nucleotide sequence to be expressed (for example, an algal promoter operably linked with an algal- derived nucleotide sequence in nature). Suitable regulatory control sequences also include regulatory control sequences not naturally associated with the nucleic acid molecule to be expressed (for example, an algal promoter of one species operatively linked to a nucleotide sequence of another organism or algal species).
- a nucleic acid sequence is operably linked when it is placed into a functional relationship with another nucleic acid sequence.
- DNA for a presequence or secretory leader is operatively linked to DNA for a polypeptide if it is expressed as a preprotein which participates in the secretion of the polypeptide;
- a promoter is operably linked to a coding sequence if it affects the transcription of the sequence;
- a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation.
- operably linked sequences are contiguous and, in the case of a secretory leader, contiguous and in reading phase. Linking is achieved by ligation at restriction enzyme sites.
- the putative regulatory control sequence can be linked to a nucleic acid molecule encoding a protein that produces a detectable signal.
- the construct comprising the putative regulatory control sequence and nucleic acid may then be introduced into an alga or other organism by standard techniques, and expression of the protein monitored. For example, if the nucleic acid molecule encodes a dominant selectable marker, the alga or organism to be used is tested for the ability to grow in the presence of a compound for which the marker provides resistance.
- a regulatory control sequence is a promoter, such as a promoter adapted for expression of a nucleotide sequence in a non- vascular, photosynthetic organism.
- the promoter may be an algal promoter, for example as described in U.S. Publ. Appl. No. 2006/0234368, now U.S. Patent No. 7,449,568, issued November 11, 2008, and U.S. Publ. Appl. No. 2004/0014174, and in Hallmann, Transgenic Plant J. 1 :81-98(2007).
- the promoter may be a chloroplast specific promoter or a nuclear specific promoter.
- the promoter may an EFl- ⁇ gene promoter or a D promoter.
- the polypeptide for example a synthase, is operably linked to an EFl- ⁇ gene promoter.
- a synthase is operably linked to a D promoter.
- Other exemplary promoters that can be used in the embodiments disclosed herein include, but are not limited to, the psbA, psbD, tufA, rbcL, HSP70A, and RBCS2 promoters.
- a regulatory control sequence can be placed in a construct in a variety of locations, including for example, within coding and non-coding regions, 5' untranslated regions (e.g., regions upstream from the coding region), or 3' untranslated regions (e.g., regions downstream from the coding region).
- a regulatory control sequence can include one or more 3' or 5' untranslated regions, one or more introns, or one or more exons.
- the vector can comprise a 5' regulatory region.
- the vector can comprise a 5' regulatory region.
- 5' regulatory comprises a promoter.
- the vector can also comprise a 3' regulatory region.
- the promoter can be a constitutive promoter or an inducible promoter. Examples of inducible promoters include, for example, a light inducible promoter, a nitrate inducible promoter, or a heat responsive promoter.
- a regulatory control sequence can comprise a
- Cyclotella cryptica acetyl-CoA carboxylase 5' untranslated regulatory control sequence or a Cyclotella cryptica acetyl-CoA carboxylase 3'-untranslated regulatory control sequence for example, as described in U.S. Pat. No.:5,661,017).
- a regulatory control sequence may also encode chimeric or fusion polypeptides, such as the protein AB or SAA, that promote expression of an endogenous or exogenous nucleotide sequence or protein.
- Other regulatory control sequences can include intron sequences that may promote translation of an endogenous or exogenous sequence.
- the regulatory control sequences used in any of the vectors described herein may be inducible.
- Inducible regulatory control sequences such as promoters, can be inducible by light, for example.
- Regulatory control sequences may also be autoregulatable. Examples of autoregulatable regulatory control sequences include those that are autoregulated by, for example, endogenous ATP levels or by the product produced by the organism.
- the regulatory control sequences may be inducible by an exogenous agent.
- Other inducible elements are well known in the art and may be adapted for use in the present disclosure.
- an expression vector comprises one or more regulatory control sequences operatively linked to a nucleotide sequence encoding a polypeptide. Such sequences may, for example, upregulate secretion, production, or both, of a product described herein.
- an expression vector comprises one or more regulatory control sequences operatively linked to a nucleotide sequence encoding a polypeptide that effects, for example, upregulates secretion, production, or both, of a product.
- such vectors include promoters.
- Promoters useful in the present disclosure may come from any source (e.g., viral, bacterial, fungal, protist, or animal).
- the promoters contemplated for use herein can be, for example, specific to photosynthetic organisms, prokaryotic or eukaryotic non- vascular photosynthetic organisms, vascular photosynthetic organisms (e.g., flowering plants), yeast, or non-photosynthetic bacteria.
- the promoter can be, for example, a promoter for expression in a chloroplast and/or other plastid organelle.
- the promoter can be a promoter for expression in a bacterial host including, for example, a cyanobacteria.
- the promoter is chloroplast based.
- promoters contemplated for use in the present disclosure include those disclosed in U.S. Application No.: 2004/0014174.
- the promoter can be a constitutive promoter or an inducible promoter.
- a promoter typically includes necessary nucleic acid sequences near the start site of transcription, (e.g., a TATA element).
- a "constitutive" promoter is a promoter that is active under most environmental and developmental conditions.
- An “inducible” promoter is a promoter that is active under environmental or developmental regulation.
- inducible promoters/regulatory elements include, for example, a nitrate-inducible promoter (for example, as described in Bock et al, Plant MoI. Biol. 17:9 (1991)), or a light-inducible promoter, (for example, as described in Feinbaum et al, MoI Gen. Genet. 226:449 (1991); and Lam and Chua, Science 248:471 (1990)), or a heat responsive promoter (for example, as described in Muller et al., Gene 111: 165-73 (1992)).
- C. reinhardtii To select integration sites and/or determine codon usage, the genome of C. reinhardtii can be consulted.
- the entire chloroplast genome of C. reinhardtii is available to the public on the world wide web, at the URL " http://www.chlamy.org/chloro/default.html", which is incorporated herein by reference.
- the chloroplast genome is also described in GenBank Ace. No.:AF396929, and in Maul, J.E., et al., Plant Cell 14 (11), 2659-2679 (2002).
- a portion of the nucleotide sequence of the chloroplast genomic DNA is selected as an integration site, such that it is not a portion of a gene, a regulatory sequence or a coding sequence, especially where integration of exogenous DNA would produce a deleterious effect with respect to the chloroplast and/or host cell (e.g., replication of the chloroplast genome).
- the chloroplast vector, p322 is a clone extending from the Eco (Eco RI) site at about position 143.1 kb to the Xho (Xho I) site at about position 148.5 kb of the C. reinhardtii chloroplast genome (http://www.chlamy.org/chloro/default.html).
- a vector utilized in the practice of the disclosure also can contain one or more additional nucleotide sequences that confer desirable characteristics on the vector, including, for example, sequences such as cloning sites that facilitate manipulation of the vector, regulatory elements that direct replication of the vector or transcription of nucleotide sequences contain therein, or sequences that encode a selectable marker.
- the vector can contain, for example, one or more cloning sites such as a multiple cloning site, which can, but need not, be positioned such that an exogenous or endogenous polynucleotide can be inserted into the vector and operatively linked to a desired element.
- the vector can also contain a prokaryote origin of replication (ori), for example, an E. coli ori or a cosmid ori, thus allowing maintenance of the vector into a prokaryote host cell, as well as in a plant chloroplast, as desired.
- ori prokaryote origin of replication
- the vectors of the present disclosure will contain elements such as an S. cerevisiae origin of replication.
- Such features combined with appropriate selectable markers, allows for the vector to be "shuttled" between the target host cell and a bacterial and/or yeast cell, for example.
- the ability to transfer a shuttle vector of the disclosure into a secondary host may allow for the more convenient manipulation of the features of the vector.
- a reaction mixture comprising a vector comprising a polynucleotide of interest can be transformed into a prokaryote host cell such as E. coli, amplified, and collected using routine methods, and examined to identify vectors containing an insert, peptide, or construct of interest.
- the vector can be further manipulated, for example, by performing site-directed mutagenesis on the polynucleotide of interest, then again amplifying and selecting for vectors that have the mutated polynucleotide of interest.
- the shuttle vector can then be introduced into plant cell chloroplasts, for example, wherein the polypeptide of interest can be expressed and, if desired, isolated according to methods known to one of skill in the art.
- a vector can also contain additional elements such as a regulatory element.
- a regulatory element as the term is used herein, broadly refers to a nucleotide sequence that regulates the transcription or translation of a polynucleotide, or the localization of a polypeptide to which it is operatively linked. Examples include, but are not limited to, an RBS, a promoter, enhancer, transcription terminator, an initiation (start) codon, a splicing signal for intron excision and maintenance of a correct reading frame, a STOP codon, an amber or ochre codon, and an IRES.
- a regulatory element can be a cell compartmentalization signal, for example, a sequence that targets a polypeptide to the cytosol, nucleus, chloroplast membrane, or cell membrane.
- a cell compartmentalization signal e.g., a chloroplast targeting sequence
- a cell compartmentalization signal may be ligated to a gene such that, following translation of the gene, the protein is transported to the chloroplast.
- Such signals are well known in the art and have been widely reported (for example, as described in U.S. Pat. No.:5,776,689; Quinn et al., J. Biol. Chem.
- a vector, or a linearized portion thereof, may include a nucleotide sequence encoding a reporter polypeptide or other selectable marker.
- reporter or “selectable marker” refers to a polynucleotide (or encoded polypeptide) that confers a detectable phenotype.
- a reporter may encode a detectable polypeptide, for example, a green fluorescent protein or an enzyme such as luciferase, which, when contacted with an appropriate agent (a particular wavelength of light or luciferin, respectively) generates a signal that can be detected by the eye or by using appropriate instrumentation (for example, as described in Giacomin, Plant Sci. 116:59-72, 1996; Scikantha, J. Bacteriol. 178:121, 1996; Gerdes, FEBS Lett. 389:44-47, 1996; and Jefferson, EMBOJ. 6:3901-3907, 1997, fl-glucuronidase).
- a selectable marker can be, for example, a molecule that, when present or expressed in a cell, provides a selective advantage (or disadvantage) to the cell containing the marker, for example, the ability to grow in the presence of an agent that otherwise would kill the cell.
- a selectable marker can provide a means to obtain prokaryotic cells, plant cells, or both, that express the marker and, therefore, can be useful as a component of a vector of the disclosure (for example, as described in Bock, R. (2001) Journal of Moleclar Biology 312(3) 425-438).
- One class of selectable markers are native or modified genes which restore a biological or physiological function to a host cell (e.g., restores photosynthetic capability or restores a metabolic pathway).
- Other examples of selectable markers include, but are not limited to, those that confer antimetabolite resistance, for example, dihydrofolate reductase, which confers resistance to methotrexate (for example, as described in Reiss, Plant Physiol. (Life Sci.
- neomycin phosphotransferase which confers resistance to the aminoglycosides neomycin, kanamycin, and paromycin
- hygro which confers resistance to hygromycin
- trpB which allows cells to utilize indole in place of tryptophan
- hisD which allows cells to utilize histinol in place of histidine
- mannose-6-phosphate isomerase which allows cells to utilize mannose (for example, as described in WO 94/20627); ornithine decarboxylase, which confers resistance to the ornithine decarboxylase inhibitor, 2-(difluoromethyl)- DL-orni thine (DFMO; for example, as described in McConlogue, 1987, In: Current Communications in Molecular Biology, Cold Spring Harbor Laboratory ed.); and deaminase from Aspergillus terreus, which confers resistance to Blasticidin S (for example, as described in Tamura, Biosci. Biotechnol. Biochem. 59:2336-2338, 1995).
- DFMO 2-(difluoromethyl)- DL-orni thine
- Additional selectable markers include those that confer herbicide resistance, for example, a phosphinothricin acetyltransferase gene, which confers resistance to phosphinothricin (for example, as described in White et al., Nucl. Acids Res. 18:1062, 1990; and Spencer et al, Theor. Appl. Genet.
- EPSPV-synthase which confers glyphosate resistance
- glyphosate resistance for example, as described in Hinchee et al., BioTechnology 91:915-922, 1998)
- acetolactate synthase which confers imidazolione or sulfonylurea resistance
- psbA which confers resistance to atrazine
- a mutant protoporphyrinogen oxidase for example, as described in U.S. Pat. NO.:5,767,373
- markers conferring resistance to a herbicide such as glufosinate.
- Selectable markers include, for example, polynucleotides that confer dihydrofolate reductase (DHFR), neomycin, and tetracycline resistance for eukaryotic cells; ampicillin resistance for prokaryotes such as E.
- DHFR dihydrofolate reductase
- neomycin neomycin
- tetracycline resistance for eukaryotic cells
- ampicillin resistance for prokaryotes such as E.
- Reporter genes have been successfully used in chloroplasts of higher plants, and high levels of recombinant protein expression have been reported. In addition, reporter genes have been used in the chloroplast of C. reinhardtii. Reporter genes greatly enhance the ability to monitor gene expression in a number of biological organisms. For example, in the chloroplasts of higher plants, ⁇ - glucuronidase (uidA, for example, as described in Staub and Maliga, EMBOJ. 12:601-606, 1993), neomycin phosphotransferase (nptll, for example, as described in Carrer et al., MoI. Gen. Genet.
- adenosyl-3-adenyltransferase for example, as described in Svab and Maliga, Proc. Natl. Acad. Sci., USA 90:913-917, 1993
- Aequorea victoria GFP for example, as described in Sidorov et al., Plant J. 19:209-216, 1999
- reporter genes have been used as reporter genes (as described in Heifetz, Biochemie 82:655-666, 2000).
- Each of these genes has attributes that make them useful reporters of chloroplast gene expression, such as ease of analysis, sensitivity, or the ability to examine expression in situ.
- Proteins such as Bacillus thuringiensis Cry toxins have been expressed in the chloroplasts of higher plants, conferring resistance to insect herbivores (for example, as described in Kota et al., Proc. Natl. Acad. Sci., USA 96:1840-1845, 1999).
- Human somatotropin for example, as described in Staub et al., Nat. Biotechnol. 18:333-338, 2000
- a potential biopharmaceutical has also been expressed.
- several reporter genes have been expressed in the chloroplast of the eukaryotic green alga, C. reinhardtii, including aadA (for example, as described in Goldschmidt-Clermont, Nucl.
- a gene encoding a protein of interest may be fused to a molecular marker or tag.
- the tag may be an epitope tag or a tag polypeptide.
- epitope tags can comprise a sufficient number of amino acid residues to provide an epitope against which an antibody can be made, yet is short enough such that it does not interfere with the activity of the polypeptide to which it is fused.
- a tag may be unique so that an antibody raised to the tag does not substantially cross-react with other epitopes (e.g., a FLAG tag).
- Other appropriate tags that may be used, for example, are affinity tags. Affinity tags are appended to proteins so that they can be purified from their crude biological source using an affinity technique.
- tags include, but are not limited to, chitin binding protein (CBP), maltose binding protein (MBP), glutathione-s-transferase (GST), a Strep-Tagil tag, and metal affinity tags (e.g., pol(His). Positioning of tag(s) at the C- and/or N-terminal may be determined based on, for example, protein function.
- CBP chitin binding protein
- MBP maltose binding protein
- GST glutathione-s-transferase
- Strep-Tagil tag e.g., pol(His).
- Positioning of tag(s) at the C- and/or N-terminal may be determined based on, for example, protein function.
- selection of an appropriate tag and its location in relationship to the protein of interest will be based on multiple factors, including for example, the intended use of the protein and the target protein itself.
- a transformation may introduce nucleic acids into any plastid of the host alga cell (e.g., chloroplast).
- a transforming vector may be extrachromosomal (e.g., does not integrate into a genome).
- the organism transformed can be an alga.
- bacteria or yeast are transformed. Transformed cells are typically plated on selective media following the introduction of exogenous nucleic acids. This method may also comprise several steps for screening.
- a screen of primary transformants is typically conducted to determine which clones have proper insertion of the exogenous nucleic acids. Clones which show the proper integration and/or vector capture may be propagated and re-screened to ensure genetic stability. Such methodology ensures that the transformants contain the genes of interest. In many instances, such screening is performed by polymerase chain reaction (PCR); however, any other appropriate technique known in the art may be utilized.
- PCR polymerase chain reaction
- magnesium concentration may need to be adjusted upwards when PCR is performed on disrupted alga cells to which EDTA (which chelates magnesium) is added to chelate toxic metals.
- magnesium concentration may need to be adjusted upward, or downward (compared to the standard concentration in commercially available PCR kits) by about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, about 1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, or about 2.0 mM.
- the final magnesium concentration in a PCR reaction may be, for example about 0.7, about 0.8, about 0.9, about 1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, about 2.0, about 2.1, about 2.2, about 2.3, about 2.4, about 2.5, about 2.6, about 2.7, about 2.8, about 2.9, about 3.0, about 3.1, about 3.2, about 3.3, about 3.4, about 3.5 mM or higher.
- Several examples provided below utilize PCR, however, one of skill in the art will recognize that other PCR techniques may be substituted for the particular protocols described.
- a polynucleotide or recombinant nucleic acid molecule of the disclosure can be introduced into host cells, including bacteria, yeast, and algae, chloroplasts or nuclei using any method known in the art.
- a polynucleotide can be introduced into a cell by a variety of methods, which are well known in the art and selected, in part, based on the particular host cell.
- the expression vector when a bacteria is used as a host cell, the expression vector can be introduced into the host cell by any conventional method known to one of skill in the art, such as a calcium chloride or electroporation, as described, for example, in Moleculer Cloning (J. Sambrook et al., Cold spring Harbor, 1989).
- yeast When yeast is used as a host cell, the expression vector can be introduced into the host cell using a lithium or spheroplast transformation technique, for example.
- a polynucleotide can be introduced into a plant cell using various techniques.
- Such techniques include, but are not limited to: a direct gene transfer technique such as electroporation; microprojectile mediated (biolistic) transformation using a particle gun; a "glass bead method"; pollen-mediated transformation; liposome-mediated transformation; transformation using wounded or enzyme-degraded immature embryos; or transformation using wounded or enzyme-degraded embryogenic callus (for example, as described in Potrykus, Ann. Rev. Plant. Physiol. Plant MoI. Biol. 42:205-225, 1991).
- exogenous is used herein in a comparative sense to indicate that a nucleotide sequence (or polypeptide) being referred to is from a source other than a reference source, is linked to a second nucleotide sequence (or polypeptide) with which it is not normally associated, or is modified such that it is in a form that is not normally associated with a reference material.
- Plastid transformation is a method for introducing a polynucleotide into a plant cell chloroplast (for example, as described in U.S. Pat. Nos. 5,451,513, 5,545,817, and 5,545,818; WO 95/16783; and McBride et al., Proc.
- chloroplast transformation involves introducing a desired nucleotide sequence flanked by regions of chloroplast DNA, allowing for homologous recombination of the nucleotide sequence into the target chloroplast genome.
- host cells transformed with a vector as described above, include transformation with a circular or a linearized vector, or a linearized portion of a vector.
- one to 1.5 kb flanking nucleotide sequences of chloroplast genomic DNA may be used. Smaller regions of flanking sequences can be used.
- One of skill in the art would be able to determine the size of the flanking region that should be used without undue experimentation.
- point mutations in the chloroplast 16S rRNA and rpsl2 genes which confer resistance to spectinomycin and streptomycin, can be utilized as selectable markers for transformation (for example, as described in Svab et al., Proc. Natl. Acad. ScL, USA 87:8526-8530, 1990), and can result in stable homoplasmic transformants, at a frequency of approximately one per 100 bombardments of target leaves.
- Microprojectile mediated transformation also can be used to introduce a polynucleotide into a plant cell chloroplast (for example, as described in Klein et al., Nature 327:70-73, 1987).
- This method utilizes microprojectiles such as gold or tungsten, which are coated with the desired polynucleotide by precipitation with calcium chloride, spermidine or polyethylene glycol.
- the microprojectile particles are accelerated at high speed into a plant tissue using a device such as the BIOLISTIC PD-1000 particle gun (BioRad; Hercules Calif.).
- BIOLISTIC PD-1000 particle gun BioRad; Hercules Calif.
- Microprojectile mediated transformation has been used, for example, to generate a variety of transgenic plant species, including cotton, tobacco, corn, hybrid poplar and papaya.
- Important cereal crops such as wheat, oat, barley, sorghum and rice also have been transformed using microprojectile mediated delivery (for example, as described in Duan et al., Nature Biotech. 14:494-498, 1996; and Shimamoto, Curr. Opin. Biotech. 5:158-162, 1994).
- the transformation of most dicotyledonous plants is possible with the methods described above. Transformation of monocotyledonous plants also can be transformed using, for example, biolistic methods as described above, protoplast transformation, electroporation of partially permeabilized cells, introduction of DNA using glass fibers, and the glass bead agitation method.
- Transformation frequency may be increased by replacement of recessive rRNA or r- protein antibiotic resistance genes with a dominant selectable marker, including, but not limited to the bacterial aadA gene (for example, as described in Svab and Maliga, Proc. Natl. Acad. Sci., USA 90:913- 917, 1993). For example, approximately 15 to 20 cell division cycles following transformation may be required to reach a homoplastidic state. It is apparent to one of skill in the art that a chloroplast may contain multiple copies of its genome, and therefore, the term "homoplasmic" or “homoplasmy” refers to the state where all copies of a particular locus of interest are substantially identical.
- Plastid expression in which genes are inserted by homologous recombination into all of the several thousand copies of the circular plastid genome present in each plant cell, takes advantage of the enormous copy number advantage over nuclear-expressed genes to permit expression levels that can readily exceed 10% of the total soluble plant protein.
- a method of the disclosure can be performed by introducing a recombinant nucleic acid molecule into a chloroplast or into the nucleus of a cell, wherein the recombinant nucleic acid molecule includes a first polynucleotide, which encodes at least one polypeptide (i.e., 1, 2, 3, 4, or more).
- a polypeptide is operatively linked to a second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth and/or subsequent polypeptide.
- several enzymes in a hydrocarbon production pathway may be linked, either directly or indirectly, such that products produced by one enzyme in the pathway, once produced, are in close proximity to the next enzyme in the pathway.
- transformation of chloroplasts is performed by co-transformation of chloroplasts with two constructs: one containing a selectable marker and a second containing the gene(s) of interest.
- the chloroplast translational apparatus generally resembles that of bacteria; chloroplasts contain 70S ribosomes; have mRNAs that lack 5' caps and generally do not contain 3' poly-adenylated tails (for example, as described in Harris et al., Microbiol. Rev. 58:700-754, 1994); and translation is inhibited in chloroplasts and in bacteria by selective agents such as chloramphenicol.
- Some methods of the present disclosure take advantage of proper positioning of a ribosome binding sequence (RBS) with respect to a coding sequence, for example, a polynucleotide of interest. It has previously been noted that such placement of an RBS results in robust translation in plants (for example, as described in U.S.
- RBS ribosome binding sequence
- polypeptides in chloroplasts are not proceed through cellular compartments typically traversed by polypeptides expressed from a nuclear gene and, therefore, are not subject to certain post-translational modifications such as glycosylation.
- the polypeptides and protein complexes produced by some methods of the disclosure can be expected to be produced without such post-translational modification.
- polynucleotide used broadly herein to mean a sequence of two or more deoxyribonucleotides or ribonucleotides that are linked together by a phosphodiester bond. As such, these terms are used interchangeably throughout the specification. These terms include, but are not limited to, RNA and DNA, a gene or a portion thereof, a cDNA, or a synthetic polydeoxyribonucleic acid sequence, and can be single stranded or double stranded, as well as a DNA/RNA hybrid.
- nucleic acid molecules which can be isolated from a cell
- synthetic polynucleotides which can be prepared, for example, by methods of chemical synthesis or by enzymatic methods such as by the polymerase chain reaction (PCR).
- the nucleotides comprising a polynucleotide can be naturally occurring deoxyribonucleotides, such as adenine, cytosine, guanine or thymine linked to 2'-deoxyribose, or ribonucleotides such as adenine, cytosine, guanine or uracil linked to ribose.
- a polynucleotide also can contain nucleotide analogs, including non-naturally occurring synthetic nucleotides or modified naturally occurring nucleotides.
- Nucleotide analogs are well known in the art and are commercially available, as are polynucleotides containing such nucleotide analogs (for example, as described in Lin et al., Nucl. Acids Res. 22:5220-5234, 1994; Jellinek et al., Biochemistry 34: 11363-11372, 1995; and Pagratis et al., Nature Biotechnol. 15:68-73, 1997).
- a phosphodiester bond can link the nucleotides of a polynucleotide of the present disclosure; however other bonds, for example, including a tbiodiester bond, a phosphorothioate bond, a peptide-like bond, and any other bond known in the art may be utilized to produce synthetic polynucleotides (for example, as described in Tarn et al., Nucl. Acids Res. 22:977-986, 1994; and Ecker and Crooke, BioTechnology 13:351360, 1995). [00229] Any of the products described herein can be prepared by transforming an organism to cause the production and/or secretion by such organism of the product.
- An organism is considered to be a photosynthetic organism even if a transformation event destroys or diminishes the photosynthetic capability of the transformed organism (e.g., exogenous nucleic acid is inserted into a gene encoding a protein required for photosynthesis).
- Any of the expression vectors described herein may be adapted for expression of a desired nucleic acid in a chloroplast or nucleus of a host organism.
- a number of chloroplast promoters from higher plants have been identified, for example, as described in Kung and Lin, Nucleic Acids Res. 13: 7543-7549 (1985).
- a chloroplast can be transformed by an expression vector comprising a nucleic acid sequence that encodes for a protein.
- the protein may be targeted to the chloroplast by a chloroplast targeting sequence.
- targeting an expression vector or the gene product(s) encoded by an expression vector to the chloroplast may further enhance the effects provided by the regulatory control sequences described herein, and may effect the expression of a protein or peptide that allows for or improves the accumulation of a fuel molecule.
- a nucleotide sequence encoding a terpene synthase may be operably linked to a nucleotide sequence encoding a chloroplast targeting sequence and the "linked" sequence then cloned into an expression vector.
- a host cell is then transformed with the expression vector and may produce more of the synthase as compared to a host cell transformed with an expression vector encoding terpene synthase but not a chloroplast targeting sequence.
- the increased terpene synthase expression may also result in more of the terpene (e.g., fusicoccadiene) being produced.
- an expression vector comprising a nucleotide sequence encoding an enzyme that produces a product (e.g. fuel product, fragrance product, or insecticide product), not naturally produced by the organism, by using precursors that are naturally produced by the organism as substrates, is targeted to the chloroplast.
- a product e.g. fuel product, fragrance product, or insecticide product
- targeting the enzyme to the chloroplast production of the product may be increased in comparison to a host cell, wherein the enzyme is expressed, but not targeted to the chloroplast. Without being bound by theory, this may be due to increased precursors being produced in the chloroplast and thus, more products may be produced by the enzyme encoded by the introduced nucleotide sequence.
- variant polypeptide enzymes are generated by look-through mutagenesis, walk-through mutagenesis, gene shuffling, directed evolution, or sexual PCR. These methods allow for the generation of variant polypeptides containing random sequence(s), variant polypeptides made using predetermined modifications of particular residues, variant polypeptides that utilize evolutionary traits from different genes, and variant polypeptides that combine characteristics/functions of different parent genes.
- the method of walk-through mutagenesis comprises introducing a predetermined amino acid into each and every position in a predefined region (or several different regions) of the amino acid sequence of a parent polypeptide. Walk-through mutagenesis is further described in greater detail in US
- Patent No. 5,798,208 which is hereby incorporated by reference in its entirety.
- Look-through mutagenesis comprises introducing a predetermined amino acid into a selected set of positions, or a position, within a defined region (or several different regions) of the amino acid sequence of a parent polypeptide. Look-through mutagenesis is further described in greater detail in
- Gene shuffling is a method for recursive in vitro or in vivo homologous recombination of pools of nucleic acid fragments or polynucleotides. Mixtures of related nucleic acid sequences or polynucleotides are randomly fragmented, and reassembled to yield a library or mixed population of recombinant nucleic acid molecules or polynucleotides. The equivalents of some standard genetic matings may also be performed by "gene shuffling" in vitro. For example, a "molecular backcross" can be performed by repeated mixing of the mutant's nucleic acid with the wild-type nucleic acid while selecting for the mutations of interest.
- the mixed population of the specific nucleic acid sequence is introduced into bacterial or eukaryotic cells under conditions such that at least two different nucleic acid sequences are present in each host cell.
- Variant polypeptides of the disclosure having altered properties can also be produced using "Sexual PCR.”
- amplified or cloned polynucleotides possessing a desired characteristic for example, encoding a polypeptide with a region of higher specificity to a substrate
- are selected via screening of a library of polynucleotides, for example) and pooled.
- Variant polypeptides of the disclosure having altered properties can also be produced using "Sequence Saturation Mutagenesis".
- sequence Saturation Mutagenesis every nucleotide in a selected range of nucleotides is randomized using an early termination/extension protocol, described in Wong et al.
- Examples of organisms that can be transformed using the compositions and methods herein include prokaryotic or eukaryotic organisms.
- the organism is photosynthetic and can be vascular or non- vascular.
- Organisms useful herein can be of unicellular or multicellular organism.
- a host organism is an organism comprising a host cell.
- the host organism is photosynthetic.
- a photosynthetic organism is one that naturally photosynthesizes (has a plastid) or that is genetically engineered or otherwise modified to be photosynthetic.
- a photosynthetic organism may be transformed with a construct of the disclosure which renders all or part of the photosynthetic apparatus inoperable.
- a host organism is non-vascular and photosynthetic.
- the host organism is prokaryotic.
- examples of some prokaryotic organisms of the present disclosure include, but are not limited to, cyanobacteria (e.g., Synechococcus, Synechocystis, Athrospira, Gleocapsa, Oscillatoria, and Pseudoanabaena ) and E. coli.
- the host organism can be unicellular or multicellular.
- the host organism is eukaryotic, for example, algae (e.g., microalgae, macroalgae, green algae, red algae, or brown algae) or fungi (e.g., yeast such as S.
- the green algae is Chlorphycean.
- the host cell is a microalga. Examples of organisms contemplated herein include, but are not limited to, rhodophyta, chlorophyta, heteronochphyta, tribophyta, glaucophyta, chlorarachniophytes, euglenoids, haptophyta, cryptomonads, dinoflagellata, and phytoplankton.
- non- vascular photosynthetic organism refers to any macroscopic or microscopic organism, including, but not limited to, algae, protists (such as euglena), cyanobacteria and other photosynthetic bacteria, which does not have a vascular system such as that found in higher plants.
- non- vascular photosynthetic organisms include bryophytes, such as marchantiophytes or anthocerotophytes.
- the organism is a cyanobacteria, or algae (e.g., macroalgae or microalgae).
- the algae can be unicellular or multicellular algae.
- the algae can be a species of Chlamydomonas, Scenedesmus, Chlorella, or Nannochloropsis, for example.
- microalga include, but are not limited to, Chlamydomonas reinhardtii, D. salina, H. pluvalis, S. dimorphus, Chlorella vulgaris, N. salina, N. oculata, D. viridis, and D. tertiolecta.
- the microalgae Chlamydomonas reinhardtii may be transformed with a vector, or a linearized portion thereof, encoding a fusicoccadiene synthase.
- the alga is C. reinhardtii 137c.
- the organism can be a photosynthetic bacterium.
- a photosynthetic bacterium can be, for example, a member of the genus Synechocystis, Synechococcus, or Athrospira.
- Also described herein are methods for utilizing non-photosynthetic bacteria as hosts to produce, for example, terpenoids.
- the terpenoid is, for example, fusicoccadiene.
- Non- photosynthetic bacteria can be useful for producing terpenoids as non-metabolized products.
- various E. CoIi strains such as BL 21 or Bacillus spp. can be used in the present disclosure.
- yeast host cells can be accomplished by complementation, transformation, homologous recombination, or other methods known to one of skill in the art. Genetic modification of bacterial cells can be accomplished, for example, by transient or stable transformation, or by modification of the bacterial genome. Techniques for transforming bacteria are well known to one of skill in the art.
- methods and compositions of the present disclosure can also be performed using prokaryotic or eukaryotic organisms, for example, microorganisms.
- non-photosynthetic bacteria including, but not limited to, Escherischia coli and Bacillus spp. can be utilized as host organisms for the embodiments disclosed herein.
- fungi in particular yeasts including, but not limited to Saccharomyces cerevisiae, Schizosaccharomcyes pombe, and Candida spp. can be utilized as host organisms for the embodiments disclosed herein.
- the methods and compositions of the disclosure can be practiced using any plant having chloroplasts, including, for example, microalga and macroalgae. Examples of such plants are marine algae and seaweed, as well as plants that grow in soil.
- Methods and compositions of the disclosure can generate a plant (e.g., alga) containing chloroplasts or a nucleus that is genetically modified to contain a stably integrated polynucleotide (for example, as described in Hager and Bock, Appl. Microbiol. Biotechnol. 54:302-310, 2000).
- a plant e.g., alga
- a nucleus that is genetically modified to contain a stably integrated polynucleotide
- the present disclosure further provides a transgenic (transplastomic) plant, which comprises one or more chloroplasts and/or a nucleus comprising a polynucleotide encoding one or more endogenous or exogenous polypeptides (such as a terpene/terpenoid synthase), including a polypeptide or polypeptides that can specifically associate to form a functional protein complex, for example, a fusicoccadiene synthase.
- a transgenic (transplastomic) plant which comprises one or more chloroplasts and/or a nucleus comprising a polynucleotide encoding one or more endogenous or exogenous polypeptides (such as a terpene/terpenoid synthase), including a polypeptide or polypeptides that can specifically associate to form a functional protein complex, for example, a fusicoccadiene synthase.
- the photosynthetic organism is a plant.
- plant is used broadly herein to refer to a eukaryotic organism containing plastids, particularly chloroplasts, and includes any such organism at any stage of development, or to part of a plant, including a plant cutting, a plant cell, a plant cell culture, a plant organ, a plant seed, and a plantlet.
- a plant cell is the structural and physiological unit of the plant, comprising a protoplast and a cell wall.
- a plant cell can be in the form of an isolated single cell or a cultured cell, or can be part of higher organized unit, for example, a plant tissue, plant organ, or plant.
- a plant cell can be a protoplast, a gamete producing cell, or a cell or collection of cells that can regenerate into a whole plant.
- a seed which comprises multiple plant cells and is capable of regenerating into a whole plant, is considered plant cell for purposes of this disclosure.
- a plant tissue or plant organ can be a seed, protoplast, callus, or any other groups of plant cells that is organized into a structural or functional unit.
- Exemplary useful parts of a plant include harvestable parts and parts useful for propagation of progeny plants.
- a harvestable part of a plant can be any useful part of a plant, for example, flowers, pollen, seedlings, tubers, leaves, stems, fruit, seeds, roots, and the like.
- a part of a plant useful for propagation includes, for example, are seeds, fruits, cuttings, seedlings, tubers, rootstocks, and the like.
- the photosynthetic organism is a vascular plant.
- Non-limiting examples of such plants include various monocots and dicots, including high oil seed plants such as high oil seed Brassica (e.g., Brassica nigra, Brassica napus, Brassica hirta, Brassica rapa, Brassica campestris, Brassica carinata, and Brassica juncea), soybean ⁇ Glycine max), castor bean (Ricinus communis), cotton, safflower (Carthamus tinctorius), sunflower ⁇ Helianthus annuus), flax (Linum usitatissimum), corn (Zea mays), coconut (Cocos nucifera), palm (Elaeis guineensis), oilnut trees such as olive (Olea europaea), sesame, and peanut (Arachis hypogaea), as well as Arabidopsis, tobacco, wheat, barley, oats, amaranth, potato, rice,
- high oil seed plants
- halophilic e.g., Dunaliella salina, D. viridis, or D. tertiolectd
- D. salina can grow in ocean water, salt lakes (salinity from about 30 to about 300 parts per thousand), and high salinity media (e.g., artificial seawater medium, seawater nutrient agar, brackish water medium, or seawater medium, for example).
- a host cell comprising a vector of the present disclosure can be grown in a liquid environment which is about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, about 1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, about 2.0, about 2.1, about 2.2, about 2.3, about 2.4, about 2.5, about 2.6, about 2.7, about 2.8, about 2.9, about 3.0, about 31., about 3.2, about 3.3, about 3.4, about 3.5, about 3.6, about 3.7, about 3.8, about 3.9, about 4.0, about 4.1, about 4.2, about 4.3 molar, or higher concentrations of sodium chloride.
- salts sodium salts, calcium salts, sulfate salts, or potassium salts, for example
- a halophilic organism may be transformed with any of the vectors described herein.
- D. salina may be transformed with a vector which is capable of insertion into the chloroplast genome and which contains nucleic acids which encode a terpene producing enzyme (e.g., fusicoccadiene synthase).
- Transformed halophilic organisms may then be grown in high-saline environments (e.g., salt lakes, salt ponds, or high-saline media, for example) to produce the product(s) of interest. Isolation of the product(s) may involve removing a transformed organism from a high-saline environment prior to extracting the product(s) from the organism.
- Host cells can be grown under conditions which result in the production of a desired product, such as a terpene or terpenoid (e.g., fusicoccadiene).
- a desired product such as a terpene or terpenoid (e.g., fusicoccadiene).
- a terpene or terpenoid e.g., fusicoccadiene.
- alga e.g., C. reinhardtii
- growth in a liquid environment containing sufficient nitrogen, phosphorous and other essential elements may be required.
- a non- photosynthetic bacterium such as E. coli
- growth on solid or liquid media may be appropriate to induce production of the desired product.
- the growth environment is an aqueous environment.
- a host organism may be grown under conditions which permit photosynthesis, however, this is not a requirement (e.g., a host organism may be grown in the absence of light). In some instances, the host organism may be genetically modified in such a way that its photosynthetic capability is diminished and/or destroyed. In growth conditions where a host organism is not capable of photosynthesis (e.g., because of the absence of light and/or genetic modification), typically, the organism will be provided the necessary nutrients to support growth in the absence of photosynthesis.
- a culture medium in (or on) which an organism is grown may be supplemented with any required nutrient, including an organic carbon source, nitrogen source, phosphorous source, vitamins, metals, lipids, nucleic acids, micronutrients, and/or any organism-specific requirement.
- Organic carbon sources include any source of carbon which the host organism is able to metabolize including, but not limited to, acetate, simple carbohydrates (e.g., glucose, sucrose, or lactose), complex carbohydrates (e.g., starch or glycogen), proteins, and lipids.
- a host organism transformed to produce a protein described herein, for example, a synthase can be grown on land, e.g., ponds, aqueducts, landfills, or in closed or partially closed bioreactor systems.
- Organisms, such as algae can be grown directly in water, for example, in oceans, seas, lakes, rivers, or reservoirs. In embodiments where algae are mass-cultured, the algae can be grown in high density photobioreactors.
- algae can be grown in high density photobioreactors (see, for example, Lee et al, Biotech. Bioengineering 44:1161-1167, 1994) and other bioreactors (such as those for sewage and waste water treatments) (for example, as described in Sawayama et al, Appl. Micro. Biotech., 41:729-731, 1994). Additionally, algae may be mass-cultured to remove heavy metals (for example, as described in Wilkinson, Biotech. Letters, 11:861-864, 1989), hydrogen (for example, as described in U.S. Patent Application Publication No. 20030162273), and pharmaceutical compounds.
- high density photobioreactors see, for example, Lee et al, Biotech. Bioengineering 44:1161-1167, 1994
- other bioreactors such as those for sewage and waste water treatments
- algae may be mass-cultured to remove heavy metals (for example, as described in Wilkinson, Biotech. Letters, 11:861-864, 1989), hydrogen (for
- host organism(s) are grown near ethanol production plants or other facilities or regions (e.g., cities or highways, for example) generating CO 2 .
- the methods discussed herein include business methods for selling carbon credits to ethanol plants or other facilities or regions generating CO 2 while making fuels by growing one or more of the modified organisms described herein near the ethanol production plant.
- the pH of the media in which the host organism is grown may be controlled.
- the pH may be controlled using the addition of various acids.
- the acids used to control pH may include CO 2 , nitric acid, phosphoric acid, or other acids.
- the pH of the media may be controlled to remain within the range of about pH 7.5 to about 8, about 8 to about 8.5, about 8.5 to about 9, about 9 to about 9.5, about 9.5 to about 10, about 10 to about 10.5, about 10.5 to about 11, or about 11 to about 11.5.
- the organisms may be grown in outdoor open water, such as ponds, the ocean, the sea, rivers, waterbeds, marsh water, shallow pools, lakes, or reservoirs, for example.
- the organisms can be contained in a halo-like object comprising lego-like particles.
- the halo object encircles the algae and allows it to retain nutrients from the water beneath, while keeping it in open sunlight.
- organisms can be grown in containers wherein each container comprises 1 or 2 or a plurality of organisms.
- the containers can be configured to float on water.
- a container can be filled by a combination of air and water to make the container and the host organism(s) in it buoyant.
- a host organism that is adapted to grow in fresh water can thus be grown in salt water (i.e., the ocean) and vice versa. This mechanism allows for the automatic death of the organism if there is any damage to the container.
- a plurality of containers can be contained within a halo-like structure as described above. For example, up to 100, up to 1,000, up to 10,000, up to 100,000, up to 1,000,000, or more containers can be arranged in a meter-square of a halo-like structure.
- the product e.g. fuel product
- the product is collected by harvesting the organism. The product may then be extracted from the organism. In some instances, the product may be produced without killing the organisms. Producing and/or expressing the product may not render the organism unviable. In other instances, the product may be secreted into a growing environment.
- the product-containing biomass can be harvested from its growth environment (e.g.
- the product-containing biomass can be subjected to a drying process. Alternately, an extraction step may be performed on wet biomass.
- the product-containing biomass can be dried using any suitable method.
- Non-limiting examples of drying methods include sunlight, rotary dryers, flash dryers, vacuum dryers, ovens, freeze dryers, hot air dryers, microwave dryers and superheated steam dryers. After the drying process the product-containing biomass can be referred to as a dry or semi-dry biomass.
- the production of the product e.g.
- fuel product is inducible.
- the product may be induced to be expressed and/or produced, for example, by exposure to light.
- the production of the product is autoregulatable.
- the product may form a feedback loop, wherein when the product (e.g. fuel product, fragrance product, or insecticide product) reaches a certain level, expression or secretion of the product may be inhibited.
- the level of a metabolite of the organism may inhibit expression or secretion of the product.
- endogenous ATP produced by the organism as a result of increased energy production to express or produce the product may form a feedback loop to inhibit expression of the product.
- production of the product may be inducible, for example, by an exogenous agent.
- an expression vector for effecting production of a product in the host organism may comprise an inducible regulatory control sequence that is activated or inactivated by an exogenous agent.
- EXAMPLE 1 Synthesis of codon biased genes encoding fusicoccadiene synthase.
- a nucleic acid (SEQ ID NO: 1) encoding Phomopsis amygdali fusicoccadiene synthase
- the codon biased PaFS with a Strep tag II described in Example 1 above was introduced into E, coli BL-21 cells.
- the nucleic acid sequence encoding fusicoccadiene synthase with a Strep tag II (SEQ ID NO: 8) was ligated into the plasmid pST7, a customized vector using a T7 promoter and terminator and containing Ndel and Xbal sites for addition of the synthetic fusicoccadiene gene.
- the resulting plasmid was transformed into E. coli BL-21 (DE3) pLysS cells (Novagen).
- the purified protein was also assayed for activity.
- the enzyme was incubated in an assay mixture containing IPP and 1- 13 C-DMAPP (DMAPP with one carbon uniformly labeled with 13 C).
- the products of the reaction were extracted with heptane and analyzed by GC/MSD.
- the GC column was changed, resulting in a small change in retention time as the column length was increased.
- the result is shown in Figure 6A, demonstrating the mass spectrum of the product (both the m/Z 272 molecular ion and the m/Z 229 fragment) was shifted by +lamu (peak eluted at 12.50 min).
- EXAMPLE 3 Biosynthesis of fusicocca-2.10(14Vdiene in E. coli in vivo.
- EXAMPLE 4 Algal expression of fusicoccadiene synthase.
- SEQ ID NO: 8 described in Example 1 was cloned into two algal expression vectors: 1) Chlamydomonas expression vector pSE-3HB-Kan-tD2; a vector containing a Kanamycin resistance gene driven by the Chlamydmonomas atpA promoter, fusicoccadiene synthase driven by the tD2 promoter (i.e., a truncated Chlamydomonas D2 promoter), and flanked by homologous regions to drive integration into the Chlamydomonas chloroplast genome 3HB site; 2) Chlamydomonas expression vector pSE-Dl-Kan; a vector containing a Kanamycin resistance gene driven by the Chlamydomonas atpA promoter, fusicoccadiene synthase driven by the Dl promoter, and flanked by homologous regions to drive integration into the Chlamydomonas chloroplast genome Dl site resulting in replacement of the native Dl gene.
- the algal expression vector pSE-3HB-Kan-tD2 containing SEQ ID NO:8 was introduced into the chloroplast of the algal host strains (strain backgrounds 1690 and 137c, both mating type positive) using biolistic gold followed by growth on TAP plates with kanamycin selection (50 ⁇ g/ml). Colonies were screened for homoplasmicity and the presence of the fusicoccadiene synthase gene by PCR. Cultures (2ml) of gene positive, homoplasmic algae were collected by centrifugation, resuspended in 250 ⁇ l of methanol. 500 ⁇ l of saturated NaCl in water and 500 ⁇ l of petroleum ether were added to the resuspended cultures.
- EXAMPLE 5 Codon optimization of PaFS in algal host cells with different genetic background.
- Figure 7B shows the mass spectrum of an algal extract from wild type C. reinhardtii 1690 cells that lack the PaFS gene according to PCR screening (gene negative).
- Figure 7C shows the mass spectrum for an algal extract from cells containing the PaFS "hot” codon bias gene in C. reinhardtii 1690 from Example 4.
- the "Hot" codon optimized clone SEQ ID NO:8 produced a much stronger fusicoccadiene signal than the "Regular” codon optimized clone (SEQ ID NO: 5).
- EXAMPLE 6 Production of fusicoccadiene in Svnechocvstis sp. strain PCC6803.
- the nucleic acid encoding the "hot" codon bias of PaFS (IS-88; SEQ ID NO: 8) was cloned into the cyanobacterium Synechocystis, downstream of the truncated lrtA promoter from PCC 6803, with the 3'-UTR of the gene encoding the S-layer protein from L. br ⁇ vis as the terminator sequence.
- the truncated lrtA has previously been demonstrated to constitutively drive protein expression in PCC 6803.
- the regions of homology utilized for integration into the chromosome were from the 1 kb regions surrounding the psbY gene, a disposable subunit of the Synechocystis photosystem.
- the vector contains a kanamycin marker for antibiotic selection at a concentration of 5 ug/mL.
- Figure 1OB is the mass spectrometry data for clone number one (0036-88-1) confirming the presence of the fusicoccadiene ions as described in example 4.
- FIG. 13 A and 13B respectively.
- the extracted ion chromatogram contains a peak at 12.5 minutes that gives the characteristic mass spectrum for fusicoccadiene containing ions 135, 229 and 272.
- EXAMPLE 7 Expression of the C-terminal domain of fusicoccadiene synthase.
- Figure 12 shows the total ion chromatograms of three reaction mixture extracts as analyzed by GC/MSD.
- One sample was of the standard compound, another sample was of the untransformed E. coli cells, and the third sample is of E. coli expressing the GGPP synthase as described above.
- geraniol elutes at time 14.3 minutes.
- EXAMPLE 8 Cloning and transformation of PaFS homologs.
- a GenBank database search for nucleic acids with sequence similarity to PaFS was performed.
- the hot codon optimized nucleic acid encoding protein ACLA 076850 including the Strep-tag sequence (SEQ ID NO:57) encodes the protein sequence of SEQ ID NO:58.
- the synthesized genes were cloned into several expression vectors: 1) bacterial expression vector behind the T7 promoter as described in Example 2; 2) Chlamydomonas expression vector behind the tD2 promoter as described in Example 4; 3) Chlamydomonas expression vector behind the Dl promoter as described in Example 4; and 4) Cyanobacterial expression vector behind the tlrtA promoter as described in Example 6.
- the host cells are cultured in conditions appropriate for bacteria (as described in Example 2), algae (as described in Example 4), or cyanobacteria (as described in Example 6). Cell extracts were prepared and tested for terpenoid production by the GC/MSD described in Example 2. [00293] EXAMPLE 9.
- a gene from Phaeosphaeria nodorum was identified from Genbank (SEQ ID NO: 9) as encoding ent-Kaurene Synthase (SEQ ID NO: 10).
- a "hot" codon optimized sequence was synthesized by DNA 2.0 (SEQ ID NO: 13) encoding the ent-kaurene synthase with an N-terminal FLAG tag (SEQ ID NO: 14).
- SEQ ID NO: 13 was cloned into the algal expression vector pSE-3HB-Kan-tD2 and transformed into C. reinhardtii as described in Example 4.
- Transformants were grown to mid-log phase and collected by centrifugation and resuspended in brine. Cells were lysed by bead beating with zirconium beads. Whole cell lysates were extracted with 1 mL of heptane by vigorous vortexing. The resulting emulsion was clarified by centrifugation and the heptane was transferred to a glass vial containing a small amount of silica gel. The sample was vortexed and the silica gel allowed to settle. The heptane layer was than analyzed by GC/MSD.
- the mass spectrum ( Figure 14B) of the peak at 8.36 minutes shows the characteristic ions of ent-kaurene including 229, 257, and 272.
- Chlamydamonas cells lacking the gene for ent-kaurene were extracted following the same procedure for use as a negative control.
- the total ion chromatogram of the organic extract of these samples does not contain a peak at 8.36 minutes ( Figure 14C).
- the mass spectrum of the strong peak at 8.28 minutes does not contain the ions for ent-kaurene namely, 229, 257 and 272 ( Figure 14D).
- Ent-kaurene synthase was also cloned and expressed in Scenedesmus cells.
- the codon optimized ent-Kaurene synthase (SEQ ID NO: 13) was cloned into the Scenedesmus chloroplast expression vector pO4-138, which uses the Scenedesmus psbD promoter to drive expression and recombines into the chloroplast genome in an intergenic region near the psbA site.
- the vector also contains the chloramphenicol acetyl transferase resistance gene driven by the Scenedesmus tufA promoter. Transformants were produced as described in Example 4, except selection was on 25 ⁇ g/ml chloramphenicol instead of kanamycin.
- FIG. 15A shows the total ion chromatogram for an extract of a Scenedesmus sample that was gene positive for ent-kaurene synthase.
- the mass spectrum of this peak shown in Figure 15B contains the molecular ion of 272 as well as the characteristic 229 and 257 ions.
- Scenedesmus cells which do not contain the ent-kaurene synthase gene were used as a negative control.
- the total ion chromatogram of the organic extracts from this sample shows no peak at 7.9 minutes (Figure 15C).
- EXAMPLE 10 Expression of Casbene synthase in algal host cells.
- a gene from Ricinus communis was identified from Genbank (SEQ ID NO: 15) as encoding Casbene Synthase (SEQ ID NO: 16).
- Genbank Genbank
- SEQ ID NO: 16 A "hot” codon optimized sequence was synthesized by
- SEQ ID NO:20 SEQ ID NO:20 was cloned into the algal expression vector pSE-3HB-Kan-tD2 and transformed into C. reinhardtii as described in Example 4.
- Transformants are grown to mid log phase. Cells are collected by centrifugation and are resuspended in brine. Cells are lysed by bead beating with zirconium beads. Whole cell lysates are extracted with 1 mL of heptane by vigorous vortexing. The resulting emulsion is clarified by centrifugation and the heptane supernatant is transferred to a glass vial containing a small amount of silica gel. The sample is vortexed and the silica gel is allowed to settle. The heptane layer is then analyzed by GC/MSD.
- EXAMPLE 11 Synthesis and expression of codon-biased gene encoding a fusion of casbene synthase and geranylgeranyl diphosphate synthase.
- amino acid residues 1-546 are from the casbene synthase gene
- amino acid residues 547-932 are from the geranyl geranyl diphosphate synthase gene.
- SEQ ID NO: 24 was cloned into the pSE-3HB-k-tD2 expression vector and transformed into C. reinhardtii as described in Example 4.
- Transformants were grown to produce a 1 L liquid culture. This culture was steam distilled using hexane as the solvent according to the method of H. Maarse and R. Kepner (1970) J.
- Figure 17B shows the mass spectrum of this peak.
- the characteristic ions for casbene are present including: 229, 257 and 272.
- No gene for casbene synthase is present in C. reinhardtii and the wild-type organism does not produce or accumulate casbene.
- EXAMPLE 12 Production of fusicoccadiene in yeast.
- both the PCR product and vector pPIC3.5 are digested with BamHI and EcoRI; the vector digest is treated with Calf Intestinal Phosphatase, and the digested vector and PCR product are run out on an agarose gel.
- the gel is stained with ethidium bromide, and the bands corresponding to the digested vector and insert are purified from the gel.
- the vector and insert are mixed, ligated, and transformed into E. coli. After transformation, the bacteria are plated onto LB solid agar plates containing ampicillin. Resistant colonies are expanded and DNA is prepared from the bacteria, and the vector is again digested with
- EXAMPLE 13 Higher plant expression of fusicoccadiene synthase.
- the DNA in (SEQ ID NO: 8) is amplified by PCR using Primer 1 (C ACC ATGGAATTTAAATATTC AGAAG (SEQ ID NO: 59) and Primer 2 (TTATTTCTCAAATTGAGGGTG (SEQ ID NO: 60).
- the primers add a directional topoisomerase cloning sequence to the 5' end of the IS-88 gene.
- the PCR product is mixed with the pENTR/D-TOPO vector and transformed into E. coli. After transformation, the bacteria are plated onto LB solid agar plates containing 50 ⁇ g/ml kanamycin. Resistant colonies are grown and DNA is isolated from the cells.
- the cloning vector containing the IS-88 gene and Gateway recombination sequences is digested with MIuI and mixed with pEarleyGatelO4 DNA and clonase, according to the Invitrogen directions. The reaction mixture is transformed into E. coli and plated onto LB solid agar plates containing 50 ⁇ g/ml kanamycin. Resistant colonies are isolated and the plasmid DNA is isolated.
- the expression vector pEarleyGatelO4-IS-88 is introduced into Agrobacterium tumefaciens according to directions provided with the "Agrobacterium transformation kit” (MPBiomedicals Life Sciences, Solon, OH). Kanamycin-resistant Agrobacterium cells are isolated on Agrobacterium medium agar (MPBiomedicals Life Sciences, Solon, OH) containing kanamycin. [00312] To produce transgenic higher plants, A.
- tumefaciens bacteria containing the pEarleyGatelO4-IS88 plasmid are grown in Agrobacterium medium and used to transform Arabidopsis thaliana seedlings according to the method of Clough and Bent (1998, Plant Journal 16:735-743). Transgenic plants are identified by resistance to treatment with the herbicide glufosinate. [00313] Transgenic whole Arabidopsis plants are grown to maturity and ground in a mortar and pestle using ImI of methanol per plant. The ground up suspension is transferred to a 2ml centrifuge tube.
- EXAMPLE 14 Use of a diterpene synthase as a readout of isoprenoid pathway metabolic flux.
- genetic induction of changes in flux through the isoprenoid pathway can be determined by quantifying fusicoccadiene levels.
- Algae expressing fusicoccadiene synthase are modified genetically by a number of means, including mutagenesis, breeding, introduction of other transgenes, or gene silencing using recombinant nucleic acids (for example, siRNA or miRNA).
- the quantity of fusicoccadiene present is measured as above.
- the relative amount of fusicoccadiene present again reflects the flux through the isoprenoid pathway.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15936609P | 2009-03-11 | 2009-03-11 | |
PCT/US2010/026445 WO2010104763A1 (en) | 2009-03-11 | 2010-03-05 | Biofuel production in prokaryotes and eukaryotes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2406378A1 true EP2406378A1 (de) | 2012-01-18 |
EP2406378A4 EP2406378A4 (de) | 2013-04-24 |
Family
ID=42728678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10751219.6A Withdrawn EP2406378A4 (de) | 2009-03-11 | 2010-03-05 | Biokraftstoffproduktion in prokaryoten und eukaryoten |
Country Status (4)
Country | Link |
---|---|
US (2) | US20120058535A1 (de) |
EP (1) | EP2406378A4 (de) |
BR (1) | BRPI1008958A2 (de) |
WO (1) | WO2010104763A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5670346B2 (ja) | 2008-12-23 | 2015-02-18 | マトリックス ジェネティクス, エルエルシー | グリコーゲンが低減した、改変された光合成微生物および炭素ベースの生成物を生成することにおけるその使用 |
US20120252054A1 (en) * | 2009-09-15 | 2012-10-04 | Sapphire Energy Inc | System for transformation of the chloroplast genome of scenedesmus sp. and dunaliella sp. |
US8980613B2 (en) | 2010-04-06 | 2015-03-17 | Matrix Genetics, Llc | Modified photosynthetic microorganisms for producing lipids |
FI20106190A0 (fi) | 2010-11-12 | 2010-11-12 | Valtion Teknillinen | Menetelmä terpeenien tuottamiseksi |
EA201400836A8 (ru) * | 2012-01-23 | 2016-03-31 | ДСМ АйПи АССЕТС Б.В. | Получение дитерпена |
CA2873405A1 (en) * | 2012-05-11 | 2013-11-14 | Donald Danforth Plant Science Center | Methods for high yield production of terpenes |
WO2015027209A2 (en) | 2013-08-22 | 2015-02-26 | Kiverdi, Inc. | Microorganisms for biosynthesis of limonene on gaseous substrates |
WO2016020689A1 (en) * | 2014-08-06 | 2016-02-11 | The Texas A&M University System | Processes and products for enhanced biological product |
CN104673813B (zh) * | 2015-03-24 | 2017-07-28 | 武汉大学 | 一种蛇孢假壳素类化合物母核合成基因AuOS及其应用 |
US10889835B2 (en) | 2016-05-27 | 2021-01-12 | The Regents Of The University Of California | Production of monoterpene blends by unicellular photosynthetic microorganisms |
MX2020000369A (es) * | 2017-07-13 | 2020-08-17 | Radici Chimica S P A | Metodos biologicos para preparar terpenos. |
CN108485982A (zh) * | 2018-03-20 | 2018-09-04 | 江苏师范大学 | 一种利用三种混合抗菌剂进行莱茵衣藻培养过程中除菌的方法 |
CN110551645A (zh) * | 2019-08-08 | 2019-12-10 | 中国农业科学院植物保护研究所 | 萜烯合酶基因GhTPS14在合成橙花叔醇方面的应用 |
EP4133063A1 (de) | 2020-04-08 | 2023-02-15 | Københavns Universitet | Herstellung von geranyldiphosphat-abgeleiteten verbindungen |
CN114410674B (zh) * | 2022-01-30 | 2024-02-23 | 深圳大学 | 一种提高衣藻半萜含量的转基因系统及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR022383A1 (es) * | 1998-09-18 | 2002-09-04 | Univ Kentucky Res Found | Sintasas |
MXPA04010432A (es) * | 2002-04-23 | 2005-05-27 | Scripps Research Inst | Expresion de polipeptidos en cloroplastos, y composiciones y metodos para expresar los mismos. |
JP2008245628A (ja) * | 2007-03-30 | 2008-10-16 | Osaka Univ | フシコッカン合成キメラ型酵素およびその遺伝子 |
-
2010
- 2010-03-05 EP EP10751219.6A patent/EP2406378A4/de not_active Withdrawn
- 2010-03-05 US US13/255,888 patent/US20120058535A1/en not_active Abandoned
- 2010-03-05 BR BRPI1008958-6A patent/BRPI1008958A2/pt not_active IP Right Cessation
- 2010-03-05 WO PCT/US2010/026445 patent/WO2010104763A1/en active Application Filing
-
2014
- 2014-08-28 US US14/472,028 patent/US20150010978A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
SASSA T ET AL: "Fusicocca-3(16), 10(14)-diene, and beta- and delta-araneosense, new fusicoccin biosynthesis-related diterpene hydrocarbons from Phomopsis amygdale", BIOSCIENCE BIOTECHNOLOGY BIOCHEMISTRY, JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, TOKYO, JAPAN, vol. 68, no. 7, 1 January 2004 (2004-01-01), pages 1608-1610, XP003023921, ISSN: 0916-8451, DOI: 10.1271/BBB.68.1608 * |
See also references of WO2010104763A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20120058535A1 (en) | 2012-03-08 |
WO2010104763A1 (en) | 2010-09-16 |
EP2406378A4 (de) | 2013-04-24 |
BRPI1008958A2 (pt) | 2015-09-01 |
US20150010978A1 (en) | 2015-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150010978A1 (en) | Terpene and terpenoid production in prokaryotes and eukaryotes | |
US9145528B2 (en) | Methods of preparing oil compositions for fuel refining | |
EP2765198A2 (de) | Isoprenoidherstellung mittels genetisch modifizierter Chloroplasten | |
US9695372B2 (en) | Methods of producing organic products with photosynthetic organisms | |
AU2008302339B2 (en) | Methods for refining hydrocarbon feedstocks | |
US8987433B2 (en) | Variant isoprenoid producing enzymes and uses thereof | |
US20190062775A1 (en) | Salt tolerant organisms | |
WO2010019813A2 (en) | Production of fatty actds by genetically modified photosynthetic organisms | |
WO2011034936A1 (en) | Herbicide resistant organisms | |
US20150089690A1 (en) | Sodium hypochlorite resistant genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110929 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130321 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/52 20060101AFI20130315BHEP Ipc: C12N 9/00 20060101ALI20130315BHEP Ipc: C12N 1/21 20060101ALI20130315BHEP Ipc: C12N 15/63 20060101ALI20130315BHEP Ipc: C12P 5/00 20060101ALI20130315BHEP Ipc: C12N 1/13 20060101ALI20130315BHEP Ipc: C12N 1/15 20060101ALI20130315BHEP |
|
17Q | First examination report despatched |
Effective date: 20131204 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SAPPHIRE ENERGY, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20161005 |